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Abstract 
 
Functional interpretation of high-throughput sequencing (HTS) data provides 
insight into biological systems, including important pathways in the context under study. 
A common approach is gene set enrichment (GSE) testing. GSE emerged in the age of 
microarrays as a way to biologically interpret long lists of differentially expressed genes 
(DEGs). However, HTS data has characteristics not present in microarray data that can 
bias GSE results. My thesis is focused on identifying, characterizing, and accounting for 
biases to improve functional interpretation in HTS data.  
In this thesis, I present GSE tests designed for ChIP-seq data and RNA-seq 
data. Our tests have applications beyond HTS data, which we show by using them to 
analyze genomic features, including mappability and repeat content. ChIP-Enrich is a 
GSE test for ChIP-seq data. It includes a database of locus definitions to annotate 
peaks to different gene loci (such as exons, introns, promoters, and other intergenic 
regions), which allows for biological discovery unique to different regions. ChIP-Enrich 
empirically adjusts for the observed bias due to the varying lengths of these gene loci in 
its enrichment test. RNA-Enrich is a GSE test for RNA-seq data. RNA-Enrich corrects 
for the selection bias often observed in RNA-seq data, where long and highly expressed 
genes are more likely to be identified as DEGs. Unlike other GSE tests for RNA-seq 
data, RNA-Enrich does not require permutations or a cut-off to define DEGs, and works 
well with small sample sizes. For both ChIP-Enrich and RNA-Enrich, we showed well-
calibrated type I error compared to competing methods. Finally, we characterize 
sequence mappability, which is one potential bias in the interpretation of HTS data. We 
characterize properties of the main contributors of low mappability (transposons and 
segmental duplications), overall mappability, and their relationship with gene locus 
length and function. Across different transcribed and regulatory regions, certain gene 
functions showed unique signatures involving significantly more/fewer associated 
xviii 
 
repeats, higher/lower mappability, and longer/shorter locus length. Our analyses provide 
insight into evolutionary selection pressures that maintain complexity of gene regulation. 
Overall, we demonstrate that considering characteristics of the human genome is 
essential to improving functional interpretation of HTS data. 
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 Introduction Chapter 1
1.1 Introduction 
The era of high-throughput sequencing (HTS), also known as next-generation 
sequencing or massively parallel sequencing, has inspired progress in genomics that 
has produced an incredible amount of data. Along with generating the data, researchers 
have also developed various algorithms for each step of data processing. What starts 
as a multitude of short DNA sequences eventually undergoes quality control, genome 
alignment, gene assignment or quantitation, a myriad of statistical analyses, and then, 
finally, interpretation [1, 2]. Since the assembly of the human genome, we have 
expanded high-throughput sequencing from sequencing of full genomes to a wide 
variety of applications that can measure gene expression [3], gene regulation and 
epigenetic marks [4]. The human genome is complicated but not random. Studying it 
poses many challenges. The organization of the human genome (e.g. exon/intron 
structures, spatial organization, and sequence redundancy) [5, 6] can perpetuate as 
biases in downstream analyses of HTS studies, resulting in incorrect interpretations of 
results, and therefore also may lead researchers to draw erroneous conclusions. This 
dissertation is focused on identifying, characterizing, and accounting for such biases to 
improve functional interpretation in various HTS platforms, including RNA-seq and 
ChIP-seq. Biases due to gene length, sequencing selection, and sequence mappability 
(the ability to uniquely align short DNA sequences) will be explored. While the research 
only includes select sequencing platforms, the findings and the methodology may be 
applicable to many types of current and, perhaps, future iterations of high-throughput 
sequencing technologies. 
2 
 
1.2 Background 
1.2.1 High-throughput technologies 
In this section, I explore some basic designs of popular high-throughput 
technologies, and pros and cons of each technology as relevant to this dissertation, 
beginning with the technology that predates HTS: microarrays. Prior to HTS, 
microarrays were the tools of choice for measuring gene expression, copy number 
variation, DNA-binding (ChIP-chips), SNP genotyping, and more. They still remain 
popular in some areas of study such as DNA methylation and SNP genotyping. Gene 
expression microarrays make use of oligo hybridization and fluorescent labelling of 
probes to measure gene expression. Probes contain DNA sequence targets that are 
spread across the genome to target various parts of the gene body and/or intergenic 
regions. Probes occupy a small chip, and each sample cDNA (generated from sample 
RNA) can be PCR amplified to determine levels of expression based on the fluorescent 
signal. The Human MethylationEPIC BeadChip, for example, is the latest methylation 
microarray from Illumina and has over 850,000 probes that measure methylation using 
bisulfite-converted DNA across the genome. Many statistical applications for high-
throughput data already existed for microarrays when next-generation sequencing was 
developed. Naively, approaches developed for microarrays were applied to sequencing 
data with little regard to whether underlying assumptions were correct. As I will further 
discuss in this dissertation, understanding the differences in data from microarrays and 
from sequencing is essential in developing the right tools, and for biological 
interpretation. 
The incentive to complete the Human Genome Project inspired next-generation 
sequencing technologies, which in turn motivated the development of a variety of 
molecular methods to explore a wide range of biological phenomena. The basis of 
massively parallel sequencing requires library preparation from select fragmentation of 
DNA. Fragments are then ligated to common adaptor sequences, and optionally 
undergo multiple rounds of amplification to increase product input [7]. In RNA-seq, 
cDNA libraries can be prepared from RNA with specific features, for example those with 
a poly-A tail, a unique feature to mRNA [3]. Variations on RNA-seq to increase power to 
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detect specific isoforms and increase coverage include creating libraries that are paired-
end and/or strand-specific. RNA-seq achieves a much higher dynamic range than 
microarrays and is not subjected to the same selection bias that may occur due to probe 
placement. However, RNA-seq is not without its problems. Longer genes and more 
highly expressed genes are more likely to have more reads, and therefore are more 
likely to be called as significantly differentially expressed for many of the commonly 
used tests [8, 9]. In addition, sequenced fragments exhibit positional and sequence-
specific preferences [10]. Several methods have been proposed to correct for such 
biases at the gene level [11-13], however if left uncorrected (or corrected for poorly), 
these biases can affect interpretation at the gene function level, e.g. gene set 
enrichment testing – a topic I explore in Chapter 3 of this dissertation. 
While RNA-seq is the HTS equivalent to gene expression microarrays, ChIP-seq 
is the HTS equivalent of ChIP-chip. ChIP is chromatin immunoprecipitation, a procedure 
to study the interaction between proteins and DNA in vivo. ChIP-chip is ChIP combined 
with microarrays, whereas ChIP-seq is ChIP combined with massively parallel 
sequencing. In ChIP-seq, which is used to study genome-wide protein-DNA interactions 
(e.g. to identify transcription factor binding sites), libraries can be prepared from DNA 
bound by protein using an anti-body to target the particular protein of interest after 
crosslinking of protein and DNA, and then sample fragmentation. ChIP-seq has various 
modifications for applications beyond transcription factors. Histone modification ChIP-
seq involves using antibodies that can detect specific histone tail modifications such as 
methylation or acetylation of one of the histone amino acids in the tetramer nucleosome 
protein complex. DNase-seq bypasses the antibody and performs fragmentation by 
targeting DNase hypersensitive sites with DNaseI digestion. FAIRE-seq (Formaldehyde-
Assisted Isolation of Regulatory Elements) does not use antibodies and therefore is not 
limited to particular DNA-binding proteins. Proteins are crosslinked, followed by sample 
fragmentation, sonication, and then phenol-chloroform extraction of DNA [4, 14]. Similar 
to RNA-seq, ChIP-seq also has a selection bias, in that longer genes and genes with 
more intergenic space around them are often more likely to have an associated peak. 
Technically speaking, peaks are areas of the genome where there is a significant 
number of consensus sequence read alignments; biologically speaking, they are the 
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predicted protein-DNA binding sites. A study of the performance of a dozen popularly 
used peak calling algorithms [15] (including MACS, spp, and PeakSeq – three peak 
callers that have been used by the ENCODE consortium [16]) on ChIP-seq datasets for 
three transcription factors with different binding profiles, showed that the number of 
peaks identified can vary by tens of thousands among different peak callers. There are 
several newer peak callers [17-19] that have shown significant improvement in calling 
peaks with higher specificity – i.e. tested datasets produce peaks with high occurrence 
of binding motif and can be reproduced with ChIP and PCR. Unfortunately, it is often 
difficult to convince users to diverge from their usual protocol. Conceivably, a list of 
ChIP peaks that contains a substantial amount of false negatives may affect 
downstream analysis if certain categories of genes consistently have many peaks or 
few peaks. 
A critical step to analysis of HTS data is alignment of reads. Longer read lengths 
are more likely to uniquely align to areas of the genome but shorter reads may align to 
multiple places, and therefore are often less mappable (i.e. have less unique 
sequence). Repeats pose a problem to sequence alignment. An estimated 45% of the 
human genome consists of repetitive elements called transposons [20, 21]. As we show 
in Chapter 4, they especially have a high occurrence in introns and intergenic regions. 
Alu elements, a type of short interspersed nuclear element, make up about 11% of the 
human genome and often occur near the transcription start site (TSS) [22]. Depending 
on how non-uniquely mappable reads are handled by the chosen sequence aligner, 
ChIP-seq peaks that occur near the TSS may be less likely to be detected if the peak 
region is not highly mappable. This also applies to any other region in the genome that 
is not uniquely mappable. 
1.2.2 Gene set enrichment testing 
Gene set enrichment (GSE) testing, also known as functional analysis of genes, 
is a way to identify important gene functions that differ between two different biological 
states. We have used it, for different genomic features like mappabiilty, repeat content, 
and gene length (Chapter 4). GSE can give insights into how a biological system works, 
and perhaps which pathways are important targets. GSE emerged in the age of 
microarrays as a way to interpret the biological relevance of long lists of differentially 
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expressed genes (DEGs). Microarrays conquered the problem of obtaining gene 
expression profiles; however often the result was a list of hundreds or thousands of 
DEGs, which was simply too much information to absorb one gene at a time. The most 
common goal of GSE testing is to find pathways or biological processes that were 
affected by the conditions of an experiment. For example, in a microarray experiment 
that tested changes in gene expression before and after a drug treatment, GSE testing 
can enlighten researchers about which pathways were most affected by the treatment. 
In ChIP-seq data, one may be interested in discovering what biological processes are 
regulated by a transcription factor, or in what diseases it may play a role.  
Gene sets may be constructed with various purposes in mind. Gene Ontology 
(GO), a commonly used gene set database, describes gene products in terms of 
biological processes, molecular functions, and cellular components [23]. The Kyoto 
Encyclopedia of Genes and Genomes (KEGG) pathways is a collection of manually 
drawn pathway maps representing molecular interactions and reaction networks [24]. 
Genes can also be classified into diseases (using MeSH terms or OMIM), spatially by 
open or condensed chromatin (cytoband), drug target lists, and many more. Typically 
GSE tests for overrepresentation, or enrichment, of gene sets. If the GSE test is two-
sided, it may also test for underrepresentation, or depletion.  
Several popular GSE methods exist for microarray data that are commonly 
applied to HTS data, three of which I will highlight here: Fisher’s exact test, GSEA, and 
random sets. Fisher’s exact test (FET) is a statistical test that analyzes contingency 
tables. In the case of GSE, the table is typically 2-by-2, where rows are gene set status 
(if the gene is in the gene set or not), and columns are gene significance status (for 
example, either differentially expressed or not, have a ChIP peak or not, etc). DAVID is 
perhaps the most widely used FET-based GSE test [25, 26]. DAVID modifies the FET 
by subtracting 1 from the table cell with the number of DEGs that are in the gene set. 
This modified FET is more conservative, it reduces the unpredictability of small gene 
sets, while having minimal effect on larger gene sets. Many implementations of FET 
exist besides DAVID, including GoMiner [27, 28] and HOMER [29] – which is designed 
for HTS data, allowing for association of peaks to genes as well as GSE testing. The 
underlying assumption of FET that is often violated with HTS data is that all genes are 
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assumed to have equal power (similar type II error rate) and to be equally likely to be a 
false positive (similar type I error rate). As we show in chapters 2-4, there are several 
factors that make a gene more or less likely to be identified as differentially expressed, 
have a peak, or any differential status. 
Another widely used GSE method is GSEA, abbreviated from “Gene Set 
Enrichment Analysis”. GSEA uses a weighted Kolmogorov-Smirnov test, a non-
parametric test (i.e. it does not rely on a statistical distribution) [30, 31]. Input for GSEA 
is a ranked list of gene-level statistics, (for example, fold change ranked from most up-
regulated to most down-regulated). A running-sum of the ordered gene-level statistics of 
genes in the gene set is calculated and compared to those not in the gene set to obtain 
an enrichment score. To calculate an associated p-value, a null distribution is generated 
by permuting phenotype labels, and the original enrichment score is compared to the 
distribution of permuted enrichment scores. There are several versions of GSEA that 
have been adapted for HTS data, including GSAASeqSP [32], which permutes read 
counts of genes, and SeqGSEA [33], which permutes the negative binomial statistics 
after using DESeq to test for differential gene expression. While GSEA, and some 
GSEA-like methods give the user the option to permute genes instead of phenotype 
labels, the GSEA authors recommend doing the latter, which “preserves gene-gene 
correlations and, thus, provides a more biologically reasonable assessment of 
significance than would be obtained by permuting genes” [31]. However, this cannot be 
done with small sample sized experiments, because a sufficient number of unique 
permutations is required to obtain p-values with reasonable accuracy. Both 
GSAASeqSP and SeqGSEA recommend sample sizes of at least 6-7 in each 
phenotype for accurate GSE results. Often in HTS experiments, it is not feasible to have 
this many samples in each condition.  
Finally, I would like to describe the random sets method for GSE testing [34]. 
Random sets is, in a way, a hybrid of FET and GSEA. While FET is limited to a binary 
gene status, the random sets approach, like GSEA, allows gene level statistics to be 
any general quantitative expression score, sg, for gene g. However, the test may not 
behave properly if the distribution of scores, sg, is far from normally distributed. The 
unstandardized enrichment score for random sets is ?̅? =
1
𝑚
∫ 𝑠𝑔𝑔∈𝐶 , where m is the 
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number of genes in gene set C. Intuitively, the enrichment score of one gene set is 
compared to random sets of the same size m that are drawn from the population of G 
genes (𝐺
𝑚
), however this comparison is done with a simple theoretical formula rather 
than performed directly, resulting in a quick, reproducible result. This approach is 
equivalent to permuting gene-level statistics among the gene labels. In the case where 
𝑠𝑔 is binary, random sets reduces to FET. Newton et al (2007) showed the distribution of 
?̅? is approximately normal, and used the method of moments to determine a test 
statistic and associated p-value for enrichment. While random sets does not require a 
binary gene status like FET, nor is it limited by small sample sizes like GSEA, it does 
continue to make the assumption that all genes are equally likely to be detected as 
significant (i.e. all genes have approximately the same power and same type 1 error). I 
expand on the performance of random sets in more detail in Chapter 3. 
Other GSE tests mentioned in this dissertation belong to the class of model-
based methods. LRpath, also developed for microarray data, uses a logistic regression 
model to test whether differential expression p-values, or any significance values of 
choice, for genes in a gene set are more or less significant than those for other genes 
[35, 36]. LRpath makes the same assumption that all genes are assumed to have equal 
power and equally likely to be a false positive. In Chapter 4, we use a different logistic 
regression GSE method, Broad-Enrich [37], that uses coverage proportion of gene 
(appropriate for HTS data like ChIP-seq of histone modifications) as the values of 
interest and corrects for gene locus length. In some cases, FET, GSEA, random sets, 
and LRpath can be applied to HTS data. However, as I will explain in this dissertation, 
the underlying assumptions of these tests are often not met with HTS data. 
1.3 Overview of dissertation 
Why is it important to account for bias in gene set enrichment testing? What are 
the origins of bias in HTS data? And what can we do to correct for these biases so that 
our conclusions are biologically sound? These are important questions that I seek to 
answer in this dissertation. Functional interpretation (e.g. GSE testing) bridges the gap 
between unwieldy, often hard to organize, high-throughput sequencing data and 
biological relevance. Improving our methods for analyzing HTS data begins with 
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identification and characterization of the biases in the current state of HTS technology. It 
is important to note both technical and biological biases, as sometimes both are not 
mutually exclusive and often will affect the accuracy of conclusions that one draws from 
analyzing HTS data.  
In Chapter 2, we present a gene set enrichment test, called ChIP-Enrich, that 
was designed for ChIP-seq data and other assays that produce a list of relatively narrow 
genomic regions (peaks). To perform GSE testing with ChIP-seq data, peaks have to be 
assigned to genes. The common practice is to assign peaks (defined by their midpoints) 
to the nearest TSS. As I have mentioned before, genes with longer loci are more likely 
to have a peak assigned to them. We address the bias of gene locus length in 
assignment of ChIP-seq peaks to genes, and developed a method that empirically 
adjusts for the observed bias. In doing so, we created a database of locus definitions to 
annotate peaks to different loci, such as introns, exons, nearest TSS, and 5kb around a 
TSS, therefore requiring different locus length adjustments and allowing for biological 
discovery that may be unique to different regulatory regions. We demonstrated that 
ChIP-Enrich is able to correct for all kinds of peak-to-locus-length relationships while 
maintaining a good type I error. We also introduce the significance of correcting for 
sequence mappability, which I expound upon in Chapter 4. In the ChIP-Enrich project, 
my contributions as a co-first author, in addition to helping to write the manuscript, were: 
(1) creating the locus definitions for the available genomes; (2) calculating mappability 
values for different kmer lengths and genomes; (3) applying ChIP-Enrich to 63 different 
ENCODE ChIP-seq datasets; (4) along with co-first author Ryan Welch, performing 
permutation testing on select ENCODE datasets to show how type I error rates of ChIP-
Enrich compared to competing methods; (5) analyzing and interpreting a case study on 
a glucocorticoid receptor ChIP-seq dataset from ENCODE in respect to its regulatory 
activity in promoter and distal regions; and (6) assisting in creating the R Bioconductor 
package, chipenrich and chipenrich.data that are also employed on our website: 
http://chip-enrich.med.umich.edu/.  
In Chapter 3, we present a gene set enrichment test, RNA-Enrich, to address a 
selection bias often observed in RNA-seq data where long and highly expressed genes 
are more likely to be identified as significantly differentially expressed (i.e. not all genes 
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have the same power). We modify the random sets method to adjust for average read 
count per gene. To calculate a test statistic for gene set enrichment, we determine a 
weight based on the observed relationship between read count and significance values 
in the data. In datasets where there is no relationship, RNA-Enrich approximates 
random sets. In datasets where there is a relationship, correcting for the bias allows for 
improved identification of truly enriched or depleted gene sets. We compare RNA-
Enrich to other GSE methods: random sets, DAVID, GOseq, GSAASeqSP and 
SeqGSEA. We also implement RNA-Enrich using significance values from different 
sources, including differential gene expression p-values from two different methods and 
a corrected fold change instead of p-values. We show that using average gene read 
count as a proxy for the selection bias greatly improves the type I error compared to 
other GSE tests for RNA-seq data.  
Chapter 4 delves into sequence mappability, its relationship with repeat elements 
and gene length, and their correlation with gene function. We perform GSE testing using 
highly prevalent transposons in the human genome: L1 elements, which are a type of 
long intersperse nuclear element, and Alu elements, a type of short intersperse nuclear 
element. Together, these two repetitive elements make up an estimated 26% of the 
human genome. Segmental duplications, which are long duplications of DNA sequence 
that are 1-200kb in length and have >90% identity, make up 5% of the human genome. 
We show that across different regulatory regions, certain gene functions show unique 
enrichment signatures of Alu elements, L1 elements, segmental duplication, 
mappability, and gene length. That is, certain types of genes have significantly 
more/fewer associated repeat elements, higher/lower mappability, and longer/shorter 
gene locus length. While sequence mappability is a technical measurement that 
depends on sequence read length, we show that it can elucidate genomic architecture 
that relates to gene length and repeat elements. Our analyses gives insight into how 
evolutionary selection has been used to maintain the required complexity of gene 
regulations, and which types of genes have been most affected. 
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 ChIP-Enrich: Gene set enrichment testing for ChIP-seq Chapter 2
data 
2.1 Introduction 
Genome-wide high-throughput experiments can assess transcription factor 
binding, epigenetic marks, differential gene expression or disease association, and 
often result in thousands of identified genomic regions or genes. Gene set enrichment 
testing is one way to determine how these lists of genomic regions or genes are related 
biologically, e.g. by assessment of Gene Ontology (GO)) terms [38-40]. For ChIP-seq 
experiments, oftentimes thousands of transcription factor binding sites or histone 
modification sites are identified. Enrichment testing of this data, or with a union or 
intersection of multiple ChIP-seq datasets, can identify key biological processes, 
functions, disease gene signatures, or other biological concepts regulated by the 
factor(s) under the given experimental conditions [41]. Conversely, ChIP-seq data can 
be used to create gene sets against which other experimental datasets can be tested 
for significant enrichment, including other ChIP-seq data [42, 43]. 
Gene set enrichment tests can generally be classified as competitive [36, 39, 44], 
self-contained [31], or a hybrid [31, 45], as discussed by Efron and Tibshirani in [46]. 
The hypothesis of competitive approaches is that there is a higher proportion of 
identified genes (or a higher level of significance overall) in the gene set of interest than 
in the remaining genes. In contrast, self-contained methods only use information about 
the genes in the gene set of interest, and test whether the significance level of the set is 
greater than expected given a null hypothesis. The enrichment testing methods used for 
sets of genomic regions (ChIP-seq data), including FET and binomial based tests, are 
Chapter 2 is published as Welch RP*, Lee C*, Imbriano PM, Patil S, Weymouth TE, Smith RA, Scott LJ, Sartor 
MA: ChIP-Enrich: gene set enrichment testing for ChIP-seq data. Nucleic Acids Research 2014, 42(13). 
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all competitive approaches [40, 47]. 
Fisher’s exact test (FET), and slight variations on it, have traditionally been used 
for gene set enrichment in microarray gene expression data [39, 48-51]. FET makes the 
assumption that each gene has an equal probability of being identified as significant. 
Across gene sets, this means that each gene set is expected under the null hypothesis 
to have approximately the same proportion of significant genes as the overall proportion 
of significant genes. In contrast to microarray data, the data generated from ChIP-seq, 
RNA-Seq, and genome-wide association studies (GWAS), often show a positive 
correlation between the length of the relevant genomic region and detection of the gene 
[9, 52, 53]. In ChIP-seq data, the probability of a peak occurring within a gene or its 
surrounding non-coding sequence, which together we denote as the gene locus, is often 
positively correlated with the length of the locus [54]. Due to this correlation, genes with 
longer locus lengths contribute a disproportionate amount to the enrichment signal, and 
this bias introduced in the signal due to gene locus length violates the assumptions of 
FET. Furthermore, because many commonly tested gene sets contain genes with 
substantially longer (e.g., developmentally and nervous system related genes) or 
shorter (e.g., electron transport, rRNA processing) than average locus length [54], the 
gene sets with longer or shorter than average locus length are more or less likely, 
respectively to be detected as significantly enriched [53]. Therefore, lack of effective 
adjustment for gene locus length can lead to false positive findings.  
Several approaches have been developed to adjust for locus length in ChIP-seq 
[47], RNA-Seq (for example, GOseq) [9], and GWAS data [52, 55]. For ChIP-seq data, a 
commonly used binomial-based test asks if the total number of peaks within the loci in a 
gene set is greater than expected, given the total locus length of the gene set, the total 
number of peaks and the corresponding length of the genome (implemented in 
Genomic Regions Enrichment of Annotations Tool (GREAT)) [47, 53]. In contrast to 
FET, the assumptions of the binomial test are met when the number of peaks in a locus 
is proportional to locus length, and the variability of peak counts among genes, given 
gene locus length, is consistent with that expected by the binomial distribution.  
We examined the gene locus length-to-peak presence relationships in 63 
ENCODE ChIP-seq GM12878 datasets and found they ranged from no relationship to 
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strongly positively correlated. Given these observations, our goal was to develop a gene 
set enrichment method for ChIP-seq data (ChIP-Enrich) that empirically models and 
adjusts for the relationship between locus length and peak presence. ChIP-Enrich 
maintained the expected type I error rate (false positive rate) in all tested datasets, 
whereas FET and the binomial test did not. For each DNA binding protein (DBP), we 
asked if different (potential) regulatory region definitions would identify different 
enriched/disenriched gene sets. For the glucocorticoid receptor α (GRα), we examined 
the ability of ChIP-Enrich to detect known and potentially novel functions. Our method is 
freely available in the R Bioconductor package chipenrich and as a web-based program 
(http://chip-enrich.med.umich.edu). 
2.2 Materials and Methods 
2.2.1 Experimental ChIP-seq peak datasets 
We used ENCODE ChIP-seq peak datasets from 63 DNA binding proteins for 
cell line GM12878 [56] (see http://chip-enrich.med.umich.edu/SummaryEncode.jsp) 
(Supplementary Table 2.1). We used the existing peak calls, which were called by the 
original authors using one or two of three peak calling methods (MACS, spp or Scripture 
[57-59]). For the subset of datasets that were called by two callers (MACS and spp), we 
use results from MACS, as we generally observed a larger number of called peaks for 
MACS than for spp.  
2.2.2 Gene loci definitions and presence of peaks in a locus 
We define a gene as the region between the furthest upstream transcription start 
site (TSS) and furthest downstream transcription end site (TES) for that gene. The 
positions of the TSSs and TESs for each gene were extracted from the UCSC 
knownGene table (human genome build hg19). We removed small nuclear RNAs as 
they are likely to have different regulatory mechanisms than other genes and often 
reside within the boundaries of other genes. For gene set enrichment testing we assign 
ChIP-seq peaks to genes (based on the peak midpoint) using three primary definitions 
of a gene's designated regulatory region (locus definitions). 1) Nearest TSS: the region 
between the upstream and downstream midpoints between a gene and the two 
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adjacent genes' TSSs. This is equivalent to assigning each peak to the gene with the 
nearest TSS. 2) Nearest gene: the region from the midpoint between the TSS and the 
adjacent gene's TSS or TSE (whichever is closest) to the midpoint between the TES 
and the adjacent gene’s TSS or TES (whichever is closest). This is equivalent to 
assigning peaks to the nearest gene. 3) ≤1kb from TSS: the region within 1kb of all 
TSSs in a gene. If TSSs from the adjacent gene(s) are less than 2kb away, we use the 
midpoint between the two TSSs as the boundary of the locus for each gene. Additionally 
we define ≤5kb from TSS, using the same rules as we defined ≤1kb from TSS, and we 
define >10kb from TSS, by subtracting the 10kb regions around the TSS from the 
nearest TSS locus definition. We define peak presence in a locus as ≥ 1 peak midpoint 
within the gene locus boundaries. 
2.2.3 Gene Ontology terms 
GO terms from GO molecular functions, GO cellular components, and GO 
biological processes were extracted from Bioconductor species specific annotation 
packages and the GO.db R package. We removed genes from each GO term that do 
not exist in our gene locus definitions as these genes could not have a peak assigned to 
them. For testing in the manuscript and in our tool, we exclude GO terms with <10 
genes as they have more limited power to detect significant results, and as a rule of 
thumb logistic regression requires at least 10 events for each explaining variable [60]. In 
the manuscript, we also exclude reporting GO terms with >500 genes, as the categories 
become broader and less informative in interpreting the results. Q-values were 
calculated using all GO terms with 10-2000 genes (our tool’s defaults).  
2.2.4 Overdispersion test of peak count (given locus length) in each gene 
set 
Overdispersion is defined as higher variability in a data set than expected based 
on the distribution used to model it. The binomial test in GREAT uses a binomial 
distribution to model the combined number of peaks for all genes in a gene set, so if 
significant overdispersion in peak counts exists among genes, the binomial distribution 
assumption is not satisfied. We tested for overdispersion in the number of peaks per 
gene (given locus length) in each gene set using Tarone’s Z statistic [61]. Tarone’s Z 
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allows better estimates of overdispersion when the binomial probabilities are close to 0 
or 1 (the probabilities of having a peak for each basepair are very close to 0). We tested 
all gene sets with a minimum of 50 genes (as gene sets with fewer genes often do not 
have adequate power for this test) and a maximum of 500 genes (the maximum gene 
set size used throughout the paper). For each DBP, we reported the proportion of gene 
sets that had significantly higher variability than expected based on the binomial 
distribution (q-value≤0.05). 
2.2.5 Mappability calculations 
To estimate the mappable proportion of each gene locus for different read 
lengths, we first calculated base pair mappability for reads of lengths 24, 36, 40, 50, 75, 
and 100 base pairs using mappability data for Homo sapiens (build hg19) from the 
UCSC Genome Browser. The UCSC browser mappability tracks provide, for each base 
pair i, the reciprocal of the number of locations in the genome to which a read beginning 
at i and extending for read length K could map; a value of 1 indicates the read maps to 
one location in the genome, a smaller value indicates the read maps to two or more 
locations in the genome. We set reads with mappability <1 to 0 and calculated base pair 
mappability as the average read mappability of all possible reads of size K that include 
a specific base pair location, i,: 
𝐵𝑖 =  (
1
2𝐾 − 1
) ∑ 𝑀𝑗
𝑖+(𝐾−1)
𝑗=𝑖−𝐾+1
 (equation 1) 
where Bi is the mappability of base pair i, and Mj is the read mappability (from UCSC’s 
mappability track) of a read of length K beginning at position j. We define gene locus 
mappability, m, as the average of all base pair mappability, Bi, values for a gene locus; 
each gene locus mappability score m represents the proportion of the gene locus that is 
uniquely mappable (given the read length of the data). 
2.2.6 ChIP-Enrich method  
We developed a logistic regression approach to test for gene set enrichment 
while adjusting for log10 mappable locus length for each gene. Suppose that for a given 
set of genomic regions (referred to as peaks), we have assigned each peak to a gene 
locus. The dependent variable is a binary vector defined as 1 if ≥1 peak is assigned to a 
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gene’s locus, and 0 if none are assigned to the gene’s locus. For each gene set, the 
explanatory variable of interest is gene set membership, g, defined as 1 for genes in the 
gene set, and 0 for all other genes. Let L be the locus length, such that m∙L is the 
mappable locus length. Let  be the probability that a gene with gene set membership g, 
and adjusted for mappable locus length, has ≥1 peak. Then   1  are the 
corresponding odds that a gene, given g = 0 or 1 and mappable locus length m∙L, has 
≥1 peak. If the log-odds differ by gene set membership adjusted for (mappable) locus 
length, then we conclude that peak presence is associated with the gene set. Our model 
is: 
  1log
1
log 1010 

mLfg


   (equation 2) 
where 0 is the intercept, 1 is the coefficient of interest, and the function f(log10 
(m∙L+1)) is a binomial cubic smoothing spline term that adjusts for log10 mappable locus 
length (or log10 locus length if m is omitted). We apply the log10 transformation to locus 
length as this improves the model fit (data not shown). The smoothing spline is 
estimated with a penalized spline using a cubic spline basis fit with 10 knots distributed 
evenly throughout the data. Placing a knot at each data point as in a true smoothing 
spline would not be computationally feasible. The model is fit using penalized likelihood 
maximization, where the smoothing penalty is the squared second derivative penalty, 
and generalized cross-validation is used to choose the optimal value for the smoothing 
parameter,  [62, 63]. We use the gam function of the R package mgcv to fit the model 
[64], and the Wald statistic to test for significance of the gene set term, β1,which is 
calculated as: 
2
1ˆ
1
ˆ











s
W      (equation 3) 
 where 1ˆ  is the penalized maximum likelihood estimate for , and 1βs ˆ  is the standard 
error for 1ˆ . W is distributed as 
2 with one degree of freedom under the null hypothesis 
β1=0, and p-values are calculated accordingly for the alternative hypothesis, β1≠0. P-
values for the gene sets are corrected for multiple testing using the Benjamini-Hochberg 
false discovery rate approach [65]. To be included in the analysis, genes had to be 
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annotated in GO and have a locus defined. For example, we have 19,051 human genes 
with the nearest TSS locus definition and 16,653 (87.4%) of these genes have ≥ 1 GO 
term annotation (with no restriction for GO term size). 
2.2.7 R package and website 
Our ChIP-Enrich gene set enrichment testing method is implemented in the 
chipenrich package for the R statistical software environment and available through 
Bioconductor, and as a web version at http://chip-enrich.med.umich.edu/. We also 
provide Fisher’s exact test as an alternative enrichment method. In addition to Gene 
Ontology, we include 12 additional annotation sources containing over 20,000 total 
gene sets [35]. We currently support the human genome (hg19), mouse genome (mm9, 
mm10), and rat genome (rn4). Precomputed mappability is available for hg19 (for read 
lengths specified above) and for mm9 (read lengths 36, 40, 50, 75, and 100 base pairs). 
Users may either supply an R data frame (for the R package) or a BED format file 
containing the peak locations as input. Runtime is typically 10-14 minutes for testing all 
GO terms but varies depending on the dataset, number of cores, and choice of locus 
definition. In addition to the nearest TSS, nearest gene, ≤1kb from TSS and ≤5kb from 
TSS locus definitions, described above, in ChIP-Enrich we also offer Exons: peaks are 
assigned to gene exons, ignoring all peaks outside of an exon. Users may also supply 
their own custom locus definition and/or mappability file. This enables users to study 
functional binding patterns relative to alternative gene features (e.g., 3’UTRs) or at 
different distances from TSSs, and to use different estimates of the observable region 
for each gene locus. Diagnostic plots are available to visualize the relationship between 
locus length and proportion of genes with a peak, and to examine the proportion of 
peaks binding proximal or distal to TSSs. We also offer an ENCODE ChIP-Enrich 
Results website (http://chip-enrich.med.umich.edu/summaryReport.jsp ), where users 
can download enrichment testing results for individual DBPs or in bulk for the GM12878 
and K562 cell lines. 
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2.2.8 Fisher’s exact test for gene set enrichment testing of ChIP-seq data 
For each GO term, we tested for association of peak presence and GO term 
membership using a two-sided Fisher’s exact test. For inclusion in the analysis, genes 
had to be annotated in GO and have a locus defined.  
2.2.9 Binomial test for GO term enrichment testing of ChIP-seq data 
We used a slight modification of the one-sided binomial test for GO term 
enrichment described by Taher et al (2009) [53] and implemented in GREAT [47]. We 
calculate the one-sided probability of seeing greater than or equal to the number of 
peaks we observe for a GO term, π, with the following formula: 
∑ (
𝑛
𝑖
) 𝑝𝜋
𝑖 (1 − 𝑝𝜋)
𝑛−𝑖𝑛
𝑖=𝑘𝜋
    (equation 4) 
where n is the total number of peaks within gene loci present in any GO term, and kπ is 
the number of peaks annotated to GO term π. We define pπ as the expected proportion 
of peaks in GO term π, as the total non-gapped length of the gene loci in the GO term, 
divided by the total non-gapped length of loci with ≥1 GO term annotation. P-values are 
calculated as the probability of observing kπ or greater number of peaks in the GO term. 
Our implementation is consistent with other GO term enrichment programs which 
restrict the background gene set to those annotated in GO [66]. In contrast, GREAT 
uses the total non-gapped genome as the denominator for pπ and defines n as all 
observed peaks.  
2.2.10 Permutations to create ENCODE ChIP-Seq data with no 
biological enrichment 
We performed permutations to assess the behavior of each enrichment test 
under two null scenarios of no true enrichment. For both scenarios, we used three 
ENCODE ChIP-seq datasets from cell line GM12878: SIX5 (Figure 2.1a,d), PAX5 
(Figure 2.1b,e), and H3K27me3 (Figure 2.1c,f). For each of the two permutation 
scenarios below, we perform 300 permutations and test each permuted dataset for GO 
term enrichment (5519 GO terms) using the three tests (ChIP-Enrich, Fisher’s exact 
test, and the binomial test).  
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Under both scenarios, we do not expect to detect enrichment, as we have 
removed any association between gene membership in GO terms, and the count of 
peaks. To help visualize the two permutation scenarios, consider a data table, where 
each row represents a gene, and contains the following columns: count of peaks per 
gene, locus length of each gene, and one column for each GO term containing a (0,1) 
indicator variable for whether the gene belongs to that GO term. In the GO term 
permutations scenario, we randomly permute the count of peaks per gene and the locus 
length as a unit. This results in a dataset where genes (identified by their peak count 
and locus length) have been reassigned to new GO terms and the locus length bias 
inherent in GO terms has been removed, but the number of genes per GO term, 
correlations between GO terms, and the relationship between locus length and count of 
peaks have all been preserved. In the GO term permutation by locus length bin 
scenario, we first order the data by locus length and then randomly permute peak count 
and locus length as a unit, but restrict this permutation within successive bins of gene 
locus length (100 genes per bin). This is similar to the first scenario, but preserves the 
relationship between locus length and GO term membership.  
2.2.11 GRα analysis 
We applied ChIP-Enrich to ChIP-seq peaks for GRα data from the A549 cell line 
from Reddy et al (2009): ChIP-Seq peaks with FDR <0.02 (4,392 peaks). In Reddy et al 
(2009), sequence reads of 36mer length, were generated from Illumina GA1, aligned 
using ELAND, and peaks were called using MACS. Reddy et al. (2009) identified 209 
genes as differentially expressed based on RNA-Seq data from A549 cells that were 
treated for 1hr with 100mM of Dexamethasone (DEX) or with 0.02% Ethanol control 
(EtOH). Briefly, in Reddy et al. (2009), gene expression levels were estimated using 
ERANGE to calculate reads per kilobase per million tags sequenced (RPKM) values, 
which were then adjusted for dependence of variance on expression level. A custom 
maximum likelihood approach was used to calculate p-values for the observed change 
in gene expression between DEX-treated and ethanol-treated cells. Finally, genes with 
FDR<0.05 were called significant [67]. Using the 209 reported differentially expressed 
genes, we tested for GO term enrichment (over-representation) with the R package 
goseq [9]. For Table 3, we pruned the list of top-ranked, enriched GO terms of closely 
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related terms for presentation by removing terms whose parents, children, or siblings in 
the ontology tree were present at a higher rank in the list. We used the R package 
GO.db to determine relationships among GO terms.  
2.3 Results 
2.3.1 Observed relationship between gene locus length and presence of at 
least one peak in ENCODE ChIP-seq datasets 
We first explore the relationship between gene locus length and the presence of 
a peak in 63 ENCODE ChIP-seq datasets from tier 1 cell line GM12878 [16, 56] using a 
binomial cubic smoothing spline to model the relationship (see Experimental ChIP-seq 
peak datasets and ChIP-seq method sections of Methods) [62, 63]. GM12878 is a 
lymphoblastoid cell line, transformed using Epstein-Barr Virus, and which has a normal 
karyotype. Lymphoblasts are immature cells that typically differentiate into lymphocytes, 
and serve as a good model for functional studies as they are known to express a wide 
range of metabolic pathways [68]. This exploration of ChIP-seq data is motivated by the 
opposing assumptions underlying FET and the binomial test: for FET that there is no 
association between locus length and presence of a peak, and for binomial-based tests, 
that the number of peaks per locus is proportional to locus length. In Figure 2.1, we 
assigned peaks to the gene with the nearest TSS (see Methods) and grouped the 
ENCODE datasets based on the total number of peaks (three equal sized groups). For 
datasets with the smallest number of peaks, we noticed that a large fraction of peaks 
were close to a TSS, and there was no or little relationship between locus length and 
probability of a peak (Figure 2.1a,d; n=21) which is consistent with the assumptions of 
FET. All were transcription factor datasets. In contrast, datasets with the largest number 
of peaks tended to have the smallest proportion of peaks within 1kb of a TSS and had a 
strong positive locus length-to-peak presence relationship (Figure 2.1,f; n=21), which is 
potentially consistent with the assumptions of the binomial test. Many of these datasets 
were histone modifications that tend to occur much more widely across the genome 
than TF binding. The locus length-to-peak presence patterns within datasets with 
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intermediate numbers of peaks show larger variability and are often not consistent with 
either FET or the binomial test assumptions (Figure 2.1b,e). 
The binomial test sums the peaks over all the genes/loci in a gene set. This 
summation assumes that the underlying probability of a peak per unit length is the same 
for each gene in the gene set (and the same for each gene not in the gene set), i.e. the 
variance of peak counts among genes in a gene set is no greater than expected based 
on the binomial distribution. We tested for variability greater than that of the binomial 
distribution, in GO terms containing between 50 and 500 genes. All DBPs showed a 
substantial proportion of GO terms with significantly (FDR<0.05) higher variability than 
expected, with many DBPs having over 99% of GO terms with significant extra 
variability (Supplementary Table 2.2) (see Overdispersion test in Methods). Thus, even 
DBPs that have a strong positive relationship between number of peaks and locus 
length (Figure 2.1f) do not satisfy the binomial test assumptions.  
2.3.2 ChIP-Enrich method 
Given the observed locus length-to-peak presence relationships, we sought to 
develop a gene set enrichment testing approach for ChIP-seq data that would 
empirically model this relationship (Figure 2.2). To capture different aspects of the 
underlying regulatory biology, we define loci based on one or more genomic features, 
and assign peaks in the defined genomic regions to genes (locus definitions). In this 
paper we use as primary locus definitions: 1) the region(s) within 1kb of every TSS of a 
gene (≤1kb from TSS), 2) the region between the upstream and downstream midpoints 
between a gene’s TSS and the adjacent genes' TSSs (nearest TSS), and 3) the gene 
and half the intergenic region between adjacent genes, defined by the closest TSS/TES 
of each gene (nearest gene) (See Gene loci definitions section of Methods for more 
details). Consistent with previous observations [54], genes with long locus lengths 
defined by the nearest TSS definition were significantly enriched for neuronal 
processes, development, and adhesion (Supplementary Table 2.3), while genes with 
short locus lengths were enriched for translation and chromatin-related processes 
(Supplementary Table 2.4),  
We test for gene set enrichment using a logistic regression model, and adjust for 
the probability of a peak as a function of log10(observable locus length) using a 
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binomial cubic smoothing spline (see ChIP-Enrich method section of Methods). Since a 
logistic regression model without the smoothing spline term approximately corresponds 
to Fisher’s exact test, our model is motivated by FET while accounting for locus length. 
Because we observed that the average mappability of gene loci both differed 
substantially among genes and that many GO terms were enriched with highly or lowly 
mappable genes (Supplementary Text and Supplementary Figure 2.1), we also account 
for the average mappability of each gene locus. We calculate the proportion of each 
locus length that is uniquely mappable as the mappability score, and use locus length × 
mappability as an estimate of the observable locus length (see Mappability Methods 
section). Although mappability often improved the spline fit (Supplementary Figure 2.2), 
it had little effect on the results of these analyses. Our R package and web-based tool 
offer a number of additional options, including custom locus and mappability definitions 
(see R package and website Methods section). Thirteen gene annotation databases 
[35] are available for testing; for simplicity, we use GO terms to illustrate our method in 
our analyses below (see Gene Ontology terms Methods section).  
2.3.3 Comparison of ChIP-Enrich, Fisher’s exact test and the binomial test 
for permuted and non-permuted ENCODE datasets  
To illustrate the performance of the different tests, we selected three ENCODE 
GM12878 DBPs with different locus length-to-peak presence relationships: SIX 
homeobox 5 (SIX5) (weak relationship, Figure 2.1d), paired box 5 (PAX5) (moderate 
positive relationship, Figure 2.1e), and trimethylation of histone 3 lysine 27 (H3K27me3) 
(strong positive relationship, Figure 2.1f) (Supplementary Figure 2.3). These DBPs have 
75, 26, and 5% of peaks ≤1kb from a TSS (Figure 2.1a-c) and 4,442, 19,618 and 
41,464 total peaks, respectively. We first tested for GO term enrichment with FET, the 
binomial test, and ChIP-Enrich in the original data (see Methods for implementation 
details of FET and the binomial test). The top ranked terms from the three tests were 
highly different for H3K27me3, moderately different for PAX5, and similar for SIX5 
where several very strongly enriched GO terms were identified by all tests (Table 2.1 
Comparison of top ranked GO terms for three DBPs from cell line GM12878 using 
ChIP-Enrich, FET, and the binomial test.). However, other datasets with total peaks 
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counts similar to SIX5 (few peaks) (Figure 2.1a,d) had less agreement between the top 
ranked terms for ChIP-Enrich and the binomial test (data not shown). 
Under the null hypothesis of no true gene set enrichment, the type I error rate for 
a dataset at a given threshold α is the proportion of gene sets with p-value less than α. 
A method with type I error rate higher than the expected α level will have an increased 
number of false positives. Therefore, we investigated the type I error rates for ChIP-
Enrich, the binomial test, and FET. We assessed the type I error rate using two 
permutation scenarios that preserve the GO term correlation structure but under which 
no biological enrichment exists, and therefore none should be detected. In the first 
scenario, we grouped gene locus length and gene peak count and permuted them 
together across all genes, which removes any relationship between GO term 
membership and locus length (permutations across all genes). In the second scenario, 
we grouped locus length and gene peak count and permuted them together within bins 
of 100 genes ordered by locus length, which retains the GO term-locus length 
relationship (permutations within locus length bins) (see Permutations Methods section). 
In the permutations across all genes, ChIP-Enrich and FET showed slightly 
conservative type I error for both permutation scenarios at α=0.05 and 0.001 (Table 2.2 
and Supplementary text), with the slight deflation expected due to the discrete nature of 
the data [69]. The lack of inflation for FET was expected since this permutation breaks 
the GO term-locus length relationship. In contrast, the binomial test had very high type I 
error rates at all three tested alpha levels (Table 2.2).  
For the permutations within locus length bins, ChIP-Enrich again had the 
expected type I error rate (Table 2.2). FET showed inflation of type I error rates for 
PAX5 and H3K27me3, but not for SIX5. SIX5 shows little relationship between locus 
length and peak presence, and therefore the assumptions for FET are approximately 
satisfied. As a check of the ChIP-Enrich method, we compared the –log10(p-values) in 
the original SIX5 data and found they were highly correlated between ChIP-Enrich and 
FET (Pearson’s r=0.97), illustrating that in this case ChIP-Enrich closely approximates 
Fisher’s exact test. The binomial test again had very high type I error rates for every 
DBP, with particularly high error for H3k27me3 (minimum permuted p-value = 1 × 10-
57). Using the binomial test we observed 761 gene sets with p<0.001 in the original 
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H3k27me3 data, compared to a median of 618 for the permutated data, implying that 
most of the significant results for the original H3k27me3 data are false positives. For 
SIX5 using permutations within locus length bin, >75% of gene sets with short average 
locus lengths had p-values <0.05 with the binomial test, whereas nearly all the gene 
sets with long average locus lengths had p-values>0.9. The binomial model assumes 
that genes with longer locus length will have proportionally more peaks, which is not 
satisfied in the SIX5 data (Supplementary Figure 2.4a). We observed the same 
behavior using the GREAT program (Supplementary text and Supplementary Figure 
2.5), but not for ChIP-Enrich (Supplementary Figure 2.4b). To see whether the bias in 
ranks based on locus length for the binomial test carried over from the permuted to the 
original unpermuted data, we asked if the ranks for original and permuted SIX5 datasets 
were correlated. We observed a high correlation for the binomial test (r =0.71) between 
the ranks of results from the original SIX5 data and the average ranks from 
permutations within locus length bins, but not for permutations across all genes 
(Supplementary Figure 2.6a,b), indicating that the correlation is due to locus length. 
With ChIP-Enrich, there was no correlation between ranks of the original and permuted 
data (r =-0.02) as expected (Supplementary Figure 2.6c,d).  
To complement our permutation study, we also simulated ChIP-seq peak 
datasets with no true biological enrichment under various scenarios and tested for 
enrichment with ChIP-Enrich, the binomial test, and FET. In these simulations, the 
binomial test had an inflated type I error rate when peak counts were not proportional to 
locus length or when extra-variability (overdispersion) was added to gene peak counts. 
Only ChIP-Enrich showed the expected type I error rate in all simulations 
(Supplementary text and Supplementary Figure 2.7, Supplementary Figure 2.8). 
2.3.4 Influence of locus definition on detection of gene set enrichment  
For each of the 63 GM12878 ChIP-seq datasets, we asked if dissimilar sets of 
biologically-related genes were detected using different locus definitions, as a way to 
identify DBPs that regulate distinct biological functions from different regulatory regions. 
Comparing ChIP-Enrich results for peaks assigned to the nearest TSS to those of the 
nearest gene, we found moderate to high correlations in the enrichment results 
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(Pearson’s r=0.62-0.99 for –log10 p-values) and p-values of similar magnitude, indicating 
that the two definitions are capturing similar information.  
We observed much greater variability in comparisons between the ≤1kb from 
TSS and nearest TSS locus definitions, with four distinct patterns emerging (Figure 2.3 
and Supplementary Figure 2.9). 1) We found similar results for ≤1kb from TSS and 
nearest TSS for DBPs that tend to bind near TSSs, such as SIX5 (Figure 2.3a), and for 
a subset of other DBPs (Supplementary Figure 2.9). 2) We identified distinct GO terms 
for ≤1kb from TSS and nearest TSS for JunD and a small number of other DBPs (Figure 
2.3b). JunD showed strong enrichment for calcium ion-related terms only within 1kb of a 
TSS and enrichment for the JNK and MAPK cascades only using nearest TSS (not 
shown). JunD regulates varied physiological processes [70]; these results suggest it 
may regulate different processes from near versus far TSSs. 3) We identified much 
stronger enrichment using nearest TSS than ≤1kb from TSS for H3K36me3 (Figure 
2.3c), H3k79me2 and H4k20me1 (Supplementary Figure 2.9) which bind along gene 
bodies [71]. 4) Finally, we saw much stronger GO term enrichment using ≤1kb from 
TSS compared to nearest TSS for CTCF (Figure 2.3d), WHIP, and a subset of DBPs 
with a small percent of peaks ≤1kb from the TSS (Supplementary Figure 2.9).  
Although CTCF is a well-known insulator in intergenic regions, both CTCF-
binding and housekeeping genes are enriched in the boundary regions of genomic 
topological domains [72], and we see many of the same strongly enriched GO terms for 
CTCF binding ≤1kb from a TSS (RNA processing, mitochondrion, and cell cycle) as for 
genes identified at the boundary regions. WHIP binds to damaged DNA and in that 
capacity is not expected to bind within or near genes with specific functions [73, 74]. 
The most highly enriched gene sets for WHIP using the ≤1kb from TSS definition 
included DNA repair (p=1.1×10-17), chromatin organization (p=3.6×10-15) and cell cycle 
regulation suggesting transcriptional roles of WHIP related to its direct function in DNA 
repair. Other DBPs with relatively small percentages of peaks near a TSS also showed 
stronger ≤1kb to TSS enrichment results; these have known transcriptional functions 
and/or involvement in DNA repair (ZNF143, CHD2) [75, 76], chromatin structure (EBF1) 
[77], or centromere formation (SMC3) [78], which may explain the lack of biological 
enrichment from more distal peaks (Supplementary Figure 2.9).  
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2.3.5 ChIP-Enrich analysis of the glucocorticoid receptor α (GRα) 
We asked whether ChIP-Enrich could identify known and potential new biology of 
a well-characterized transcription factor, the glucocorticoid receptor α (GRα) [79]. 
Previous analysis identified 4,392 peaks in A549 cells treated with 100nM DEX 
(dexamethasone stimulates GR activity); only 4.7% of the peaks were within 1kb of a 
TSS (Figure 2.4a). GO term enrichment testing yielded largely distinct subsets of 
significant (FDR≤0.05) terms for nearest TSS (195 terms) and ≤1kb from TSS (72 
terms) with only 16 overlapping terms (Figure 2.4b,d; Supplementary Table 2.5). The 
most significant terms (after collapsing similar terms) are shown in Table 2.3. Terms 
significant using one or both locus definitions include “epithelial cell differentiation” (q-
values: nearest TSS=1.8×10-6; ≤1kb from TSS=1.0) and “negative regulation of blood 
coagulation” (q-values: nearest TSS=0.077, ≤1kb from TSS=3.19×10-7, with the related 
term “regulation of wound healing” (q-values: nearest TSS=0.0064, ≤1kb from 
TSS=0.0029). In addition, we observed “response to glucocorticoid stimulus” (q-values: 
nearest TSS=0.0035; ≤1kb from TSS=0.55) and “regulation of lipid metabolic process” 
(q-values: nearest TSS=0.0062, ≤1kb from TSS=0.74). GRα is known to be involved in 
the response to steroids and the activation of lipolysis [80, 81], although knowledge of 
the transcriptional role of GRα in wound healing and blood coagulation is more limited. 
We also tested for enrichment using non-overlapping locus definitions for regions closer 
to a TSS (≤5kb from TSS; 14.5% of peaks) and further from a TSS (>10kb from TSS; 
75.6% of peaks) and again identified largely distinct gene sets (Supplementary Figure 
2.10).  
We also compared the enrichment results (using nearest TSS) from ChIP-Enrich 
with those using the binomial test and FET. Due to inflated type I error rates for the 
binomial test and FET for nearest TSS, the specific p-values and number of terms with 
FDR<0.05 cannot be used. Instead, we compared the top ranked terms among the 
methods, using the number of top ranked terms with FDR <.05 for ChIP-Enrich (195). 
There was substantial overlap, with 57 (29%) GO terms identified by all three methods 
and 150 (77%) identified by at least two (Figure 2.4c). Both FET and the binomial test 
had higher overlap with ChIP-Enrich than with each other, consistent with the fact that 
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the locus length-to peak presence relationship modeled by ChIP-Enrich is intermediate 
between the assumptions of FET and the binomial test.  
To evaluate the biological relevance of our results, we compared the ChIP-seq 
enrichment results from ChIP-Enrich with RNA-Seq enrichment results based on 
differential expression between control and 100nm DEX treated A549 cells [18] (See 
GRα analysis section of Methods). Of 4,544 GO terms tested for enrichment based on 
RNA-Seq differential expression, 458 (10%) were significant at FDR≤0.05. "Vascular 
development", the most significant GO term based on differential expression, was also 
significantly enriched for GRα binding using the nearest TSS analysis (q-value=0.0047) 
but not using ≤1kb from TSS (q-value=0.97). Eighty-six (29%) of the significant terms 
from RNA-Seq were significant with one or both of the locus definitions in ChIP-seq data 
(Figure 2.4d). From the ChIP-seq perspective, many of the most highly significant terms 
using nearest TSS and <1kb from TSS were significant for RNA-Seq (Table 2.3, Figure 
2.4e,f). Seventy-two (37%) of the significant GO terms for nearest TSS were significant 
for RNA-Seq, whereas only 20 (28%) of the significant GO terms for ≤1kb from TSS 
were significant for RNA-Seq, indicating potentially stronger correspondence of the 
gene expression data with the GRα peaks captured by the nearest TSS definition than 
only those peaks ≤1kb from a TSS. Correlations with RNA-Seq results using a custom 
>10kb from TSS locus definition (see Gene loci definitions Methods section) were 
similar to nearest TSS and those for ≤5kb from TSS were similar to ≤1kb from TSS (not 
shown). GO terms enriched only in RNA-seq may be regulated by genes downstream of 
those directly regulated by GRα or be GRα-independent DEX effects. GO terms 
enriched only in ChIP-seq data may indicate pathways that are poised to be regulated, 
either from proximal promoter or more distal enhancer regions. 
2.4 Discussion 
We developed a gene set enrichment testing method for ChIP-seq data, ChIP-
Enrich, that empirically models and adjusts for the effect of gene locus length. In 
contrast to Fisher’s exact and the binomial test, ChIP-Enrich maintains the correct type I 
error rate for datasets with a wide range of locus length-to-peak presence relationships. 
FET and the binomial test make assumptions that are inconsistent with the observed 
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relationships, which can lead to inflated type I error rates (false positive results). 
Strikingly, the binomial test often has significantly more false positives than FET.  
ChIP-Enrich uses a binomial smoothing spline to empirically model the 
relationship with gene locus length; an approach similar to that employed by GOseq, 
which was developed for RNA-seq data [9]. Whereas GOseq uses either a resampling 
approach or the approximate Wallenius method to calculate GO term enrichment p-
values, ChIP-Enrich incorporates the smoothing spline in a logistic regression model, 
allowing more precise p-value calculations and in less time than a resampling approach 
requires. Compared to the Wallenius approximation, ChIP-Enrich has greater power, as 
determined by finding more significantly enriched GO terms (36% more on average) 
across the 63 GM12878 ChIP-seq datasets (data not shown). 
For many DBPs, particularly those with more binding near TSSs, testing for 
enrichment using the nearest TSS and ≤1kb from TSS locus definitions identifies largely 
overlapping gene sets, suggesting the two definitions often capture similar regulatory 
information. However, for a subset of DBPs, these two locus definitions detect very 
different enriched gene sets. JunD, for example, may be regulating different biological 
processes nearer to and further from the TSS, possibly with different cooperating 
factors. For datasets with a small proportion of peaks ≤1kb of a TSS, but stronger levels 
of enrichment detected with those peaks (examples WHIP and CTCF), it is possible that 
DBP binding >1kb from the TSS may not be properly assigned to the regulated gene(s), 
or that some of the widespread DBP binding may not regulate genes in any specific 
biological processes. Thus for DBPs with unknown function, comparisons of patterns of 
gene set enrichment could help predict an alternative role for the DBP, such as DNA 
repair and/or chromatin remodeling or looping. 
To further explore the biological relevance of our results, we compared the gene 
sets enriched for differential expression of mRNA following activation of GRα to the 
gene sets enriched for GRα binding [79]. For GRα a subset of gene sets, many of which 
were not detected using the ≤1kb from TSS locus definition and including vasculature 
development, showed substantial enrichment for both differential expression and GRα 
binding. GRα has been reported to play a limited role in vasculature development, 
mainly through non-transcription factor activities; the extent to which it directly regulates 
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vasculature development genes as a group was thus far unknown [82-84]. This 
suggests that GRα regulates many genes and functions via binding further from TSSs, 
consistent with the observations of Reddy et al (2009) [79], and this regulation would be 
missed if only peaks within 1kb were examined (such as could be tested without bias 
using FET).  
Unlike the binomial test, ChIP-Enrich results are not influenced by a single gene 
or few genes with a large number of peaks. However, because higher numbers of a 
bound DBP in a gene locus may exert stronger biological effects (49), the use of a 
model based on peak counts, that accounts for extra-variability and diverse locus 
length-to-peak count relationships, could be considered. For example, a negative 
binomial or beta binomial model may be able to account for the extra variability among 
genes in the peak count data. However, it is unclear whether these models can fully 
account for both the extra variability and the observed negative correlation between 
peak occurrence rate and locus length, or how best to empirically adjust for locus 
length. 
In conclusion, we developed a gene set enrichment testing method, ChIP-Enrich, 
which allows enrichment analysis of ChIP-seq data with any locus length-to-peak 
presence relationship with the expected type I error rate. This is in contrast to currently 
available methods, which often exhibit highly elevated type I error and/or gene set 
ranking biased towards genes with long or short locus length, leading to false positive 
results. Based on our observations, we recommend testing each set of genomic regions 
for enrichment with both a locus definition representing promoter regions (e.g., ≤1kb 
from TSS or ≤5kb from TSS) and a locus definition representing all regions or regions 
more distal to TSSs (e.g., nearest TSS, nearest gene, or >10kb from TSS). ChIP-Enrich 
can be used to further assess and refine regulatory region definitions, based on 
empirical exploration, and to identify biological functions of regions exhibiting various 
complex patterns of histone marks or protein binding using the wealth of biological data 
from ENCODE, the Roadmap Epigenomics Program and other public and non-public 
sources. With the option for user-defined locus definitions and/or mappability tracks, this 
framework can also be used with other genome-wide sequencing data such as RNA-
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Seq (with potential bias from transcript length and/or read depth) or bisulfite sequencing 
data (with potential bias from number of measured CpG sites).  
2.5 Supplementary Methods 
2.5.1 Testing for enriched GO terms with genes of longer (or shorter) than 
average locus length 
We used DAVID [85] to test for GO term enrichment in the top 500 genes with 
longest (or shortest) locus lengths. For both tests, the complete set of genes in our 
locus definition file was used as the background gene list. Results were limited to GO 
terms with ≤2,000 genes and FDR≤0.05 in order to report more specific categories. 
2.5.2 Testing for enriched GO terms with genes having higher or lower 
than average mappability 
We tested for GO terms enriched with genes having higher or lower than 
expected mappability scores using a logistic regression model with GO term 
membership as the outcome and average gene locus mappability scores as the 
predictor (LRpath [86]; lrpath.ncibi.org). Because LRpath typically accepts p-values as 
input which are then log-transformed, we exponentiated mappabililty values before input 
to preserve the original mappability scale. Results were limited to GO terms with ≤2,000 
genes and FDR≤0.05.  
2.5.3 Simulation and enrichment testing of data under the null hypothesis 
of no GO term enrichment 
We simulated ChIP-seq peaks under the null hypothesis of no association with 
any GO term. As an alternative to simulating peak locations, we randomly sampled 
genes with replacement and set the number of times the gene was selected to the count 
of peaks occurring within the locus of a gene. Genes were sampled in two ways: 1) 
randomly (not in proportion to locus length), and 2) randomly in proportion to locus 
length. The first simulates peaks occurring within genes with no dependence on locus 
length (FET assumption). The second method simulates peaks being assigned to genes 
with probability in proportion to locus length (binomial test assumption). We simulated 
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datasets of 10,000 peaks with varying percentages (0, 50 and 100%) sampled in 
proportion to locus length. For FET and ChIP-Enrich, a gene is labeled as having a 
peak if the count of peaks is ≥ 1. Each GO term was tested for enrichment using FET, 
the binomial test, and ChIP-Enrich. We repeated this process 1,000 times for each test 
and percentage of genes sampled by locus length, and calculated the median of the 
1,000 simulation p-values at each quantile of the 2,565 GO term p-values to create the 
plots for the bottom row of Supplementary Figure 2.7.  
To examine the effect of overdispersion (added variation in peak count among 
genes) on each of the three tests, we simulated data with 100% of peaks sampled by 
locus length (satisfying the binomial test assumption) but with additional overdispersion 
in number of peaks per gene. In the simulations above without overdispersion, we 
sampled genes in proportion to their locus lengths to represent ChIP-seq peaks 
occurring in gene loci, by assigning each gene a weight proportional to its locus length. 
Here, we sample genes in proportion to random deviates of their locus lengths using a 
gamma distribution with mean equal to the gene’s locus length and variance set to one 
of four different levels (0, 0.01, 0.1, 0.5) to simulate increasing overdispersion. For each 
simulation, a weight is drawn for each gene and then 10,000 draws of genes are made 
based on the weights to represent 10,000 peaks. For each gamma variance level, we 
performed 1,000 simulations. The simulated data was tested for enriched GO terms 
using FET, ChIP-Enrich and the binomial test, and results were presented as median 
quantile p-values as above (Supplementary Figure 2.8).  
Code for all simulations is available in Supplementary_code.zip.  
2.5.4 GREAT testing on permuted ChIP-seq datasets 
To confirm that our results in Supplementary Figure 2.4 were not restricted to our 
implementation of the binomial test, we repeated the analysis of GO term permutations 
by locus length bins data (permuted ENCODE datasets for SIX5, PAX5, and 
H3k27me3) with the GREAT website (Supplementary Figure 2.5). For each of the three 
experimental datasets, we used GREAT with the “single gene” setting, where “each 
gene is assigned a regulatory domain that extends in both directions to the nearest 
gene's TSS but no more than the maximum extension in one direction.” The “maximum 
extension” was set to 100,000 kb in order to insure each peak is assigned to a 
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regulatory domain (i.e. gene), which is most equivalent to our nearest TSS locus 
definition. 
2.6 Supplementary Results 
2.6.1 Effect of locus length and read mappability on gene set enrichment 
tests  
Gene set enrichment testing with Fisher’s exact test (FET) can be confounded 
when there is a positive relationship between locus length and the presence of a peak, 
since many gene sets contain genes with substantially longer or shorter locus lengths 
than average [54]. Taher and Ovcharenko (2009) identified Gene Ontology (GO) terms 
with much longer or shorter than expected gene loci (defining a locus as the gene and 
half the intergenic region between adjacent genes) [53]. Similarly, when we assigned 
peaks to the gene with the nearest TSS, we found that GO terms related to 
nucleosome, protein-DNA complexes, and translation have genes with shorter than 
average locus lengths (Supplementary Table 3) and nervous system development, cell 
adhesion, and transcription have genes with longer than average locus lengths 
(Supplementary Table 4).  
The probability of calling a ChIP-seq peak can depend on the mappability of the 
reads in the binding region [87, 88]. To account for mappability (which similar to locus 
length, varied significantly by gene set (Supplementary Figure 2.1)), we use locus 
length × mappability as the observable locus length in our analyses; this can improve 
the spline fit (Supplementary Figure 2.2), although it had little effect on the final results 
of the presented enrichment testing analyses (data not shown). To assess the ability of 
mappability to confound the relationship between the presence of a peak and gene set 
membership, we estimated the average mappability of each gene locus based on base 
pair mappabilities for 50bp reads (see Supplementary Figure 2.1a for comparison of 
mappability at different read lengths). Genes with less mappable loci are significantly 
more likely to be present in sensory, xenobiotic response and oxygen related terms, 
whereas genes with highly mappable loci are more likely to be involved in nervous 
system or development terms ( q-value < 3.0x10-16) (Supplementary Figure 2.1b,c). We 
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observed similar results at other read lengths (data not shown). Several GO terms (e.g., 
central nervous system development) had both longer locus lengths and higher 
mappability, increasing the possibility for confounding.  
In addition to mappability, GC content has also been noted to influence 
sequencability and thus detection of ChIP-seq peaks. To examine a potential bias due 
to GC content, we downloaded the UCSC Genome Browser’s GC content track for 
hg19, which provides GC content for every 5bp. We calculated average GC content for 
four definitions of gene loci (nearest TSS, exons, 1kb and 5kb), and observed very little 
spread in the distribution of GC content. Testing for GO terms enriched with low or high 
GC content genes (using the nearest TSS definition and the same LRpath approach as 
used for testing low or high mappability genes), we found only 14 significant terms as 
compared to 717 significant terms for mappability (FDR<0.05). Given the tight 
distribution of GC content among gene loci and the small number of significantly 
associated GO terms, we conclude that it is unlikely that GC content is a confounding 
variable or significantly biases the enrichment testing results. 
2.6.2 Comparison of ChIP-Enrich, Fisher’s exact test, and the binomial test 
under the null hypothesis of no enrichment using simulated data  
To examine the sensitivity of each test to varying mixtures of peak distributions 
that meet the FET or binomial test assumptions, we simulated datasets of 10,000 peaks 
with 0%, 50%, and 100% of the peaks simulated in proportion to locus length relative to 
those simulated irrespective of locus length. As the percentage of peaks simulated in 
proportion to locus length increases from 0 to 100%, the relationship between the 
probability of a gene having at least one peak and locus length changes from flat 
(Supplementary Figure 2.7a) to increasingly correlated (Supplementary Figure 2.7b,c).  
Using our simulated datasets, we tested for GO term enrichment and plotted the 
observed –log10(p-values) versus the expected –log10(p-values) under the null 
hypothesis of no enrichment in quantile-quantile (QQ) plots (Supplementary Figure 
2.7d-f.) For all three scenarios, ChIP-Enrich shows no inflation of significance levels 
from the expected distribution but has a slight deflation of the most significant p-values. 
When all peaks are simulated with each gene having equal probability of having a peak 
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(0% proportional to locus length), Fisher’s exact test shows the expected distribution of 
p-values (observed = expected) also with a slight deflation of the most significant p-
values similar to ChIP-Enrich, expected due to the discrete nature of the data [89] . With 
an increasing percentage of peaks sampled in proportion to locus length, FET becomes 
increasingly anti-conservative (Supplementary Figure 2.7d  e  f), such that p-values 
as low as 10-10 are observed in the absence of any true enrichment. The binomial test 
shows the opposite behavior; when peaks are sampled in proportion to locus length 
(100% proportional to locus length) and without any additional variability among genes 
in a gene set, the binomial test has the expected p-value distribution (again with a slight 
deflation as for FET when 0% random) but when peaks are sampled independent of 
locus length (0% proportional to locus length) the test becomes increasingly anti-
conservative (Supplementary Figure 2.7f  e  d), with even lower p-values than 
observed for Fisher’s exact test.  
2.6.3 Test behaviors in the presence of overdispersion of peak counts 
among genes, given locus length 
To better understand the difference in binomial test behavior between 1) the 
H3K27me3 dataset GO term permutation by locus length bin (which shows a strong 
inflation of significance levels despite peaks occurring approximately in proportion to 
locus length) and 2) simulations in which 100% of peaks were simulated in proportion to 
locus length (Supplementary Figure 2.8f; which shows no inflation of significance levels 
when peaks occur in proportion to locus length), we performed additional simulations 
with 100% of the peaks simulated in proportion to locus length. In these simulations, we 
added increasing levels of extra variability (overdispersion) in peak counts among 
genes (gamma variance levels of 0.01, 0.1, and 0.5). The overdispersion did not visually 
change the observed spline fit (not shown). Again, we tested for GO term enrichment 
and plotted the observed –log10(p-values) versus the expected –log10(p-values) in QQ 
plots (Supplementary Figure 2.8). As before, ChIP-Enrich shows no inflation of 
significance levels. The binomial test, however, shows increasing inflation of 
significance levels with increasing overdispersion. FET shows decreasing levels of 
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inflation with increasing overdispersion, but remained biased for each overdispersion 
scenario.  
2.6.4 Slight deflation in p-values compared to what is expected under the 
null 
When the assumptions of Fisher’s exact test are met, e.g. for the transcription 
factor SIX5, Fisher’s exact test shows a slight deflation of the most significant p-values 
compared to what is expected if we assume a uniform distribution of p-values under the 
null hypothesis. This trend is expected due to the discrete nature of the data [89]. We 
observe the same slight deflation for both ChIP-Enrich (Figure 2.3c,g,k, and 
Supplementary Figure 2.7d,e,f, and 8b) and the binomial test (Supplementary Figure 
2.7f and Supplementary Figure 2.8c) when the assumptions of the test are satisfied. 
2.6.5 Sensitivity analysis for GR 
As a sensitivity analysis we also repeated the GR analyses with a larger set of 
peaks identified using a less stringent cutoff. This set contains 15,837 peaks with p-
value ≤ 1 x10-9, equivalent to an FDR < 0.23 (Supplementary dataset 1 from Reddy et 
al.) [79]. Results using nearest TSS with the 15,837 peaks were similar to those from 
the more stringent peak calling (r =0.61 for –log10(p-value) comparison) (see 
Supplementary text), with 81/216 (38%) of the significant GO terms also significant in 
the RNA-seq enrichment analysis. However, the ≤1kb from TSS analysis results from 
the less stringent peak calling identified only 26 GO terms compared to 72 from the 
more stringent peak calling with only 8 GO termsin common. Only five (19%) of the 26 
GO terms were also significant in the RNA-seq GOseq enrichment analysis, consistent 
with our finding in the main text that there is potentially stronger correspondence of 
gene expression data with GRα binding captured by nearest TSS (mainly distal regions) 
than only those peaks ≤1kb from a TSS. 
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2.7 Figures 
 
 
Figure 2.1 Gene locus length-to-peak presence relationship becomes stronger as total number of peaks 
increases. The relationship between gene locus length and proportion of genes with ≥1 peak in a gene locus varies 
widely in 63 ENCODE ChIP-seq datasets, from no relationship to strongly positive. DNA binding proteins (DBPs) from 
the GM12878 cell line were categorized into three groups of 21 DBPs by the total number of peaks. For each DBP, 
the relationship between log10 locus length and proportion of genes with a peak was modeled using a binomial cubic 
smoothing spline (see Methods). (a-c) Barplots show the average proportion of peaks present within the specified 
distance from the TSS (kb) (gray bar) and the proportions for individual DBPs (colored dots, same color as line in the 
corresponding plot). DBPs with fewer peaks tend to have a higher proportion of binding close to TSSs. (d) The locus 
length-to peak presence relationship tends to be weak for datasets with few peaks. (e-f) The relationship becomes 
strongest when the number of peaks is highest (f). None of the DBPs in (d), two of the DBPs in (e) and 10 of the 
DBPs in (f) are histone modifications. 
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Figure 2.2. Overview of ChIP-Enrich. We describe ChIP-Enrich in four steps. (1) ChIP-seq peaks are assigned to 
genes using a chosen gene locus definition. Definitions include: nearest gene, ≤1kb from TSS and nearest TSS. (2) It 
is determined whether ≥ 1 peak is present in each gene locus. (3) Gene set enrichment is performed for each gene 
set using a logistic regression model, adjusting for locus length with a binomial cubic smoothing spline term 
(represented as f in the model equation.) (4) Data and results are summarized. a) Plot of observed spline fit for log10 
locus length versus proportion of genes with a peak (orange). Expected line if no relationship between log10 locus 
length and proportion of genes with a peak (dark gray, satisfies Fisher’s exact test assumptions). Expected line if 
number of peaks observed is proportional to locus length (light gray, binomial test assumption). For visualization only, 
each point is the proportion of genes assigned a peak within sequential bins of 25 genes; b) Barplot of proportion of 
peaks found at various distances from the TSS; c) Abbreviated ChIP-Enrich output. 
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Figure 2.3. Representative plots of the 4 patterns of enrichment comparing the ≤1kb from TSS and nearest 
TSS locus definitions. Gene set enrichment testing using the ≤1kb from TSS and nearest TSS locus definitions may 
identify similar (a) or different (b) sets of significant GO terms for the same DBP. Alternatively, most of the enrichment 
signal may come from nearest TSS which uses all peaks (c) or ≤1kb from TSS which ignores peaks >1kb from a TSS 
(d). (a-d) Upper plot: Barplot of proportion of peaks at different distances from the TSS. Lower plot: Comparison of –
log10(p-values) from ChIP-Enrich GO term enrichment testing using ≤ 1kb from TSS versus nearest TSS locus 
definitions in ENCODE data for the GM12878 cell line. GO terms enriched with FDR ≤0.05 for: ≤1kb from TSS only 
(green); nearest TSS only (blue); ≤1kb from TSS and nearest TSS (orange); neither analysis (black). r, Pearson 
correlation coefficient. These patterns are representative of patterns present in 63 ENCODE DBPs from the 
GM12878 cell line. 
 
38 
 
 
Figure 2.4 Comparison of GRα enrichment results for ChIP-seq (using two locus definitions) and RNA-seq 
data from A549 cells. Enriched GO terms for differentially expressed transcripts and GRα binding following 100nM 
DEX treatment show stronger overlap using the nearest TSS locus definition than using the ≤1kb from TSS definition. 
(a) Observed spline fit for GRα fits neither FET nor the binomial test assumption (orange); barplot of proportion of 
peaks at different distances from the TSS. See Fig 2.4.a and b for further details. (b) Using the nearest TSS locus 
definition with GRα results in more overlapping terms with RNA-seq results than using ≤1kb from TSS (c) Using the 
top 195 ranked terms for each test, FET and the binomial test have more overlap with ChIP-Enrich than with each 
other. (d-f) Comparison of –log10(p-values) for GO term enrichment tests based on ChIP-seq data (ChIP-Enrich) 
and/or RNA-seq (GOseq) data. (f) Many enriched RNA-seq terms would have been missed in the ChIP-seq data if 
only peaks in promoter regions were considered. GO terms enriched and FDR ≤0.05: for Y-axis test only (green); for 
X-axis test only (blue); for X and Y-axis tests (orange); for neither (black). Vasculature development and related GO 
terms (triangles). The majority of GO terms that overlap between ≤1kb from TSS and nearest TSS are related to fatty 
acid metabolism, reactive oxygen species and unfolded proteins, or blood coagulation. 
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2.8 Tables 
Table 2.1 Comparison of top ranked GO terms for three DBPs from cell line GM12878 using ChIP-Enrich, FET, 
and the binomial test. (a) H3K27me3, (b) PAX5, and (c) SIX5. The most extreme differences are observed for 
H3K27me3, which also had the highest type I error rate for the binomial test. Differences among the tests are more 
moderate for PAX5. SIX5 had several extremely significant GO terms with ChIP-Enrich, which were also easily 
detected by the other two methods. All tests were performed using the nearest TSS locus definition. CE=ChIP-Enrich; 
Binom=binomial test; FET = Fisher’s exact test. 
 
a H3k27me3      
 
CE 
rank 
Binom 
Rank 
FET 
rank GO term 
CE 
q-value 
Binom 
q-value 
FET 
q-value 
GO term avg 
locus 
length %ile* 
 1 898 1 extracellular matrix 1.5x10
-9
 0.013 2.2x10
-20
 69.6 
 2 14 4 regulation of hormone levels 3.3x10
-7
 4.4x10
-16
 3.9x10
-13
 58 
 3 1633 3 proteinaceous extracellular matrix 3.8x10
-7
 0.15 9.2x10
-17
 70.4 
 4 648 311 cytokine activity 2.7x10
-6
 2.6x10
-3
 1.2x10
-3
 20.9 
 5 1137 122 anchored to membrane 2.9x10
-6
 0.036 1.6x10
-5
 88.2 
 691 1 1066 3',5'-cyclic-GMP phosphodiesterase 
activity 
0.28 9.8x10
-32
 0.089 52.1 
 986 2 3715 IgG binding 0.41 1.9x10
-26
 0.77 1.8 
 256 3 2696 pancreatic ribonuclease activity 0.095 1.10x10
-24
 0.77 0.1 
 3537 4 3186 cytoplasmic dynein complex 0.87 9.28x10
-23
 1 37.4 
 2842 5 3049 localization within membrane 0.99 2.6x10
-21
 0.92 42 
 14 4946 2 synapse 1.7x10
-4
 1.0 3.6x10
-17
 91.6 
 21 1250 5 sensory organ development 8.7x10
-4
 0.053 4.6x10
-13
 77.8 
*Average locus length percentile for the top 20 terms for: ChIP-Enrich- 59.1; binomial test- 41.6; FET- 82.2. 
 
b PAX5      
 CE 
rank 
Binom 
rank 
FET 
Rank GO term 
CE 
q-value 
Binom 
q-value 
FET 
q-value 
GO term avg 
locus length %ile* 
 1 6 2 immune response-regulating 
signaling pathway 
1.4x10
-7
 1.1x10
-53
 4.5x10
-10
 39.6 
 2 4 1 immune response-activating signal 
transduction 
1.5x10
-7
 3.0x10
-54
 4.5x10
-10
 39.2 
 3 111 13 protein localization to organelle 2.8x10
-7
 9.0x10
-17
 4.8x10
-6
 27 
 4 13 66 viral reproduction 3.2x10
-7
 1.4x10
-41
 5.8x10
-4
 9.3 
 5 3 3 leukocyte activation 5.8x10
-7
 1.3x10
-54
 5.0x10
-9
 48.9 
 20 1 39 regulation of immune response 8.6x10
-5
 5.2x10
-74
 1.1x10
-4
 28.5 
 170 2 405 innate immune response 0.024 4.2x10
-61
 0.10 20.9 
 49 5 31 induction of apoptosis 5.2x10
-4
 3.3x10
-54
 8.6x10
-5
 30.9 
 6 11 4 lymphocyte activation 1.3x10
-6
 5.5x10
-44
 9.8x10
-9
 52 
 8 19 5 immune response-activating cell 
surface receptor signaling 
pathway 
7.1x10
-6
 8.7x10
-37
 4.8x10
-8
 46.7 
*Average locus length percentile for the top 20 terms for ChIP-Enrich: 25.9, binomial test: 33.3, and FET: 48.6 
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c SIX5       
 
 CE 
rank 
Binom 
rank 
FET 
Rank GO term 
CE 
q-value 
Binom 
q-value 
FET 
q-value 
GO term 
avg locus length %ile* 
 1 1 1 Ribosome 4.4x10
-32
 1.5x10
-60
 1.9x10
-34
 3.4 
 2 4 2 structural constituent of 
ribosome 
9.8x10
-25
 4.2x10
-49
 1.7x10
-27
 3.1 
 3 6 4 establishment of protein 
localization to organelle 
2.6x10
-23
 1.1x10
-43
 8.4x10
-24
 8.6 
 4 28 6 mRNA processing 6.2x10
-23
 5.8x10
-26
 2.3x10
-22
 22.7 
 5 3 5 ncRNA metabolic process 1.0x10
-22
 1.0x10
-49
 8.8x10
-23
 6.6 
 6 2 6 viral reproduction 1.1x10
-22
 1.0x10
-52
 2.3x10
-22
 9.3 
 7 5 3 ribosomal subunit 2.5x10
-22
 1.0x10
-46
 2.9x10
-24
 2.6 
*Average locus length percentile for the top 20 terms for ChIP-Enrich: 8.4, binomial test: 5.1, and FET: 8.0 
 
 
 
 
 
Table 2.2. Fisher’s exact test and the binomial test, but not ChIP-Enrich, show strongly inflated type I error 
rates. ChIP-Enrich shows the expected type I error rate in permuted ENCODE GM12878 ChIP-seq data; Fisher’s 
exact test and the binomial test can show substantial inflation of type I error rate. Values represent the proportion of 
tests with p-value less than the given 
locus length bins), a well-
number of tests was 300 permutations × 5519 GO terms = 1,655,700 tests. CE=ChIP-Enrich; Binom=binomial test; 
FET = Fisher’s exact test. 
  
 
 level = 0.05  level = 0.001  level = 10
-5
 
  
CE Binom FET CE Binom FET CE Binom FET 
Permuted 
across all 
gene 
SIX5 
0.038 0.11 0.038 6.2x10
-4
 0.012 5.9x10
-4
 6.5x10
-5
 .0033 6.4x10
-5
 
PAX5 
0.043 0.25 0.040 4.3x10
-4
 0.093 7.8x10
-4
 2.8x10
-5
 0.054 6.9x10
-5
 
H3k27me3 
0.045 0.30 0.040 4.7x10
-4
 0.14 7.4x10
-4
 3.9x10
-5
 0.096 5.1x10
-5
 
Permuted 
within locus 
length bins 
SIX5 
0.038 0.13 0.039 7.4x10
-4
 0.034 7.3x10
-4
 6.7x10
-5
 0.019 6.2x10
-5
 
PAX5 
0.043 0.25 0.073 3.9x10
-4
 0.11 0.0046 3.4x10
-5
 0.073 0.0011 
H3k27me3 
0.044 0.32 0.18 4.2x10
-4
 0.17 0.044 3.1x10
-5
 0.12 0.024 
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Table 2.3. Most significant Gene Ontology terms from GRα ChIP-Enrich analysis using nearest TSS and ≤1kb 
from TSS locus definitions show a large degree of overlap with significant GO terms from RNA-seq data from 
the same cell line. Most highly significant GO terms (after collapsing related terms; q-value ≤0.05) detected using 
ChIP-Enrich with the a) nearest TSS and b) ≤1kb from TSS locus definitions. The highest ranked GO term from each 
related set of GO terms is displayed. Bold rows designate GO terms with q-value ≤0.05 in GOseq analysis of RNA-
Seq data. In total, 458 GO terms (with ≤500 genes) were significantly enriched for the RNA-seq results.  
a 
ChIP-Enrich 
rank 
nearest TSS 
GOseq 
rank 
RNA-seq data GO Term 
___ ChIP-Enrich q-value___ 
GOseq 
q-value nearest TSS ≤1kb from TSS 
 
1 22 epithelial cell differentiation 1.8x10
-6
 1.0 1.2x10
-6
 
 2 936 adherens junction 5.3x10
-5
 1.0 0.39 
 
4 85 negative regulation of sequence-
specific DNA binding 
transcription factor activity 
5.5x10
-5
 1.0 3.0x10
-4
 
 
5 9 anti-apoptosis 5.5x10
-5
 0.34 3.2x10
-9
 
 7 1040 basolateral plasma membrane 1.7x10
-4
 1.0 0.52 
 
8 501 unsaturated fatty acid metabolic 
process 
3.2x10
-4
 0.028 0.063 
 10 872 focal adhesion 4.5x10
-4
 1.0 0.32 
 
13 132 regulation of small GTPase 
mediated signal transduction 
8.6x10
-4
 1.0 1.3x10
-3
 
 
14 95 response to inorganic substance 1.2x10
-3
 0.075 4.3x10
-4
 
 
15 1616 response to growth hormone 
stimulus 
1.4x10
-3
 1.0 1.0 
 
b 
ChIP-Enrich 
rank 
nearest TSS 
GOseq 
rank 
RNA-seq data GO Term 
 ____ChIP-Enrich q-value___ 
GOseq 
q-value ≤1kb from TSS nearest TSS 
 
1 267 negative regulation of blood 
coagulation 
3.2x10
-7
 0.077 0.010 
 
7 1143 intrinsic to external side of plasma 
membrane 
1.8x10
-4
 0.062 0.68 
 8 1648 leukotriene metabolic process 2.2x10
-4
 6.4x10
-3
 1.0 
 10 4193 anchored to plasma membrane 2.1x10
-3
 0.39 1.0 
 
14 323 positive regulation of leukocyte 
chemotaxis 
3.5x10
-3
 0.092 0.017 
 15 1091 platelet alpha granule lumen 4.7x10
-3
 0.25 0.61 
 18 1099 ameboidal cell migration 5.2x10
-3
 0.31 0.94 
 19 1108 regulation of nuclease activity 5.2x10
-3
 0.083 0.66 
 
20 192 cellular response to biotic 
stimulus 
5.2x10
-3
 6.1x10
-3
 3.7x10
-3
 
 
22 876 nucleotide-binding domain, 
leucine rich repeat containing 
receptor signaling pathway 
6.1x10
-3
 0.15 0.010 
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2.9 Supplementary Figures 
 
b) GO Terms whose Genes’ Loci Have Higher Mappability c) GO Terms whose Genes’ Loci Have Lower Mappability 
GO Term # Genes P-value Q-value GO Term # Genes P-value Q-value 
Organ morphogenesis 642 2.6E-22 5.5E-19 Olfactory receptor activity 114 1.6E-11 7.0E-09 
Central nervous system 
development 454 2.9E-19 3.0E-16 
Sensory perception of 
smell 131 1.3E-09 6.3E-08 
Neurogenesis 634 1.4E-18 9.8E-16 Cellular defense response 60 3.0E-08 9.0E-07 
Neuron differentiation 534 2.7E-18 1.4E-15 
Sensory perception of 
chemical stimulus 167 3.7E-08 1.1E-06 
Cell development 786 5.5E-18 2.3E-15 Oxygen binding 44 7.7E-08 8.7E-06 
Generation of neurons 589 1.6E-17 5.6E-15 
Cellular response to 
xenobiotic stimulus 35 2.2E-07 5.1E-06 
Skeletal system development 272 2.6E-16 7.8E-14 
Xenobiotic metabolic 
process 35 2.2E-07 5.1E-06 
Regionalization 217 1.9E-15 4.9E-13 Electron carrier activity 156 4.9E-07 3.0E-05 
 
Supplementary Figure 2.1. Gene loci with high (or low) average mappability are enriched for specific Gene 
Ontology terms. (a) Distribution of human (hg19) mappability scores (calculated as the average mappability for each 
gene locus using the nearest TSS locus definition) for five different sequencing read lengths. (b) Most significantly 
enriched GO terms associated with high mappability using 50mer reads (c) Most significantly enriched GO terms 
associated with low mappability using 50mer reads. GO biological processes and molecular functions were tested 
using the LRpath gene set enrichment program [36]. 
 
  
a) 
43 
 
 
Supplementary Figure 2.2. Using the mappable locus length (locus length x mappability) tends to improve 
the fit of the binomial cubic smoothing spline in the model, illustrated here with PAX5. Adjusting for 
mappability often shifts up the spline fit for the longest locus lengths; the dip in the fit without mappability is due to 
outlier points with long locus length and very low mappability. 
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Supplementary Figure 2.3. SIX5, PAX5, and H3K27me3 have different gene locus-length-to-peak presence 
relationships. SIX5 (also in Figure 2.1a) has a weak relationship; PAX5 (also in Figure 2.1b) has a mid-level 
relationship; H3K27me3 (also in Figure 2.1c) has a strong relationship. The relationships between locus length and 
proportion of genes with a peak were estimated using a binomial cubic smoothing spline (orange line). Expected line 
if no relationship between presence of ≥ 1 peak and log10 locus length (dark gray, satisfies Fisher’s exact test 
assumptions). Expected line if number of peaks observed is proportional to locus length (light gray, binomial test 
assumption). For visualization only, each point is the proportion of genes assigned a peak within sequential bins of 25 
genes. 
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Permutations within locus length bins – Binomial test 
30-50 genes 51-200 genes >200 genes 
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Supplementary Figure 2.4. The binomial test tends to identify gene sets with short locus length as significant 
(p < 0.05), especially for SIX5. Panel (a) shows the –log10 p-values from the binomial test versus the average log10 
locus length of each gene set tested. Each row shows results from a permutation of the DBP dataset, where the 
original DBP dataset has been permuted by shuffling genes within bins of locus length. Each column subdivides all 
gene sets by their number of genes: the first column has gene sets with 30-50 genes, the next 51-200 genes, and the 
last > 200 genes. Panel (b) shows plots as in (a) for ChIP-Enrich. The binomial test shows a trend of much larger – 
log10 p-values for gene sets with low average log10 locus length, and this trend is most pronounced for sets of genes 
with fewer than 200 genes (first and second columns.) ChIP-Enrich does not show this trend for any of the three 
datasets tested.  
 
Permutations within locus length bins – ChIP-Enrich 
30-50 genes 51-200 genes >200 genes 
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Supplementary Figure 2.5. The GREAT website test tends to detect gene sets with shorter than average locus 
length, especially for SIX5. Plots show the –log10 p-values from the GREAT test versus the average log10 locus 
length of each gene set tested. Each row show results from a permutation of the DBP dataset, where the original 
DBP dataset has been permuted by shuffling genes within bins of locus length. Each column subdivides all gene sets 
by their number of genes. Gene set enrichment testing using GREAT on each set of permuted peaks from SIX5, 
PAX5, and H3k27me3 found significantly enriched GO terms (FDR≤0.05), when none should have been detected. 
The trend with locus length was again greatest for SIX5 and least for H3k27me3. 
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Supplementary Figure 2.6. For SIX5 the ranks of the binomial test results from the original data are highly 
correlated the average ranks from 25 permutations (within locus length bins) of the original data (Spearman r 
= 0.71). For ChIP-Enrich the rank of test results from original data and the average rank permuted data are not 
correlated. The fact that this correlation is not observed in (b, permutations across all genes), implies that the 
correlation is due to the locus length bias. Each plot compares the average ranks of results from 25 permutations to 
rank in the original data, and the red dash line indicates the highest rank where FDR≤0.05 for the original data. (a) 
Binomial test results for permutations within locus length bins. Of the 509 significantly enriched (FDR≤0.05) GO terms 
(with ≤500 genes) using the original, non-permuted data, 413 (81.1%) were also significantly enriched in at least one 
of the permuted data sets. Of the 4,325 not significantly enriched GO terms, only 583 (13.5%) were enriched in at 
least one of the permuted data sets. (b) Binomial test results from permutations across all genes. The average ranks 
of the binomial test results are not correlated with the ranks of the original data (Spearman r=-0.06), indicating that 
the correlation in (a) is due to the confounding by locus length. ChIP-Enrich test results from (c) permutations within 
locus length bins and (d) permutations across all genes, respectively. In both permutation scenarios, the ranks of 
ChIP-Enrich results from permuted and the original data were not correlated (Spearman r=-0.02 and -0.005, 
respectively).   
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Supplementary Figure 2.7. Relationship in simulated datasets between locus length and presence of at least 
one peak (a-c), and QQ-plots showing the type 1 error rate of Fisher’s exact test, the binomial test, and ChIP-
Enrich under these relationships (d-f). Simulated datasets of 10,000 peaks and 0% (a, d), 50% (b, e), or 100% (c, 
f) of peaks sampled in proportion to locus length. Top row (a-c) - For visualization, each point is a bin of 25 genes, 
plotted as the average proportion of genes having a peak within the bin against the average log10 locus length. The 
dark grey horizontal line represents the model where peaks occur within genes with no relationship to their locus 
length. The light grey line represents the probability of a locus having ≥1 peak if peaks are randomly distributed 
across the genome (binomial test assumption). The purple line is a binomial smoothing spline fit to the underlying 
data (the 0/1 vector denoting whether a peak was assigned to a gene vs. the log10 locus length of each gene). The 
yellow line represents the known relationship that exists in the simulated data. Bottom row (d-f) – QQ plots showing 
Fisher’s exact and the binomial test represent two extreme assumptions for enrichment testing for ChIP-seq data, 
while ChIP-Enrich empirically estimates the correct balance between these two extremes. Incorrect assumptions at 
either end leads to biased significance levels. Median p-values (solid lines) are shown for 1000 simulations of 
Fisher’s exact test, ChIP-Enrich, and the binomial test.  
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Supplementary Figure 2.8. Increasing overdispersion in peak counts among genes increases the type 1 error 
rate of the binomial test, decreases type 1 error for Fisher’s exact test, and has no effect on ChIP-Enrich.  
QQ plots of expected versus observed –log10(p-values) for (a) Fisher’s exact test, (b) ChIP-Enrich, and (c) the 
binomial test. Increasing levels of overdispersion, modeled using a gamma distribution, were assessed ranging from 
no overdispersion (red) to a gamma distribution with variance = 0.5 (blue). Red line (no overdispersion) represents 
the same simulation as that in Supplementary Figure 2.7c,f. Simulated datasets of 10,000 peaks were used, and 
median p-values for 1000 simulations are shown.  
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Supplementary Figure 2.9. Gene set enrichment testing using ≤ 1kb from TSS and nearest TSS locus 
definitions often identifies very different sets of significant GO terms for the same DBP.  
Comparison of –log10(p-values) from testing GO terms with ChIP-Enrich using ≤ 1kb from TSS versus nearest TSS 
locus definitions in ENCODE data for the GM12878 cell line. GO terms with: FDR ≤.05 for ≤ 1kb from TSS only 
(green); FDR ≤.05 for nearest TSS only (blue); FDR ≤.05 for ≤ 1kb from TSS and nearest TSS (orange); FDR >.05 in 
both analyses (black). r: Pearson correlation coefficient. DBPs are arranged by groupings in Figure 2.1a, (a-c) are 
DBPs with low number of peaks, (d-f) are DBPs with medium number of peaks, and (g-l) are DBPs with high number 
of peaks. 
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Supplementary Figure 2.10. A comparison of ChIP-Enrich GO term enrichment results for GR using peaks 
≤5kb from the TSS and peaks >10kb from the TSS. Only 14 gene sets were significantly enriched (q≤0.05) in both 
tests. Vasculature development (shown as the blue triangle) was only significant using peaks >10kb from the TSS. 
GO terms with: FDR ≤.05 for ≤ 5kb from TSS only (green); FDR ≤.05 for >10kb from TSS only (blue); FDR ≤.05 for ≤ 
5kb from TSS and ≥10kb from TSS (orange); FDR >.05 in both analyses (black). r: Pearson correlation coefficient. 
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2.10 Supplementary Tables 
Supplementary Table 2.1. List of DBPs from Figure 2.1 with their total peak counts and associated peak 
caller. All DBPs are from ENCODE cell line GM12878. 
 
DNA binding protein Peak caller Number of peaks % of peaks ≤ 1kb from TSS 
ATF3 spp 1884 66.9 
BATF spp 24600 4.9 
BCL11A spp 13256 5.7 
BCL3 MACS 22503 13.1 
BCLAF1 MACS 29162 30.8 
BHLHE40 MACS 57698 21.7 
BRCA1 MACS 15431 40.6 
C-Fos spp 1744 81.8 
CHD2 MACS 42652 29.4 
CTCF MACS 44056 16.1 
Ctcf Scripture 61525 12.8 
EBF1 MACS 98976 14.2 
EGR1 spp 13662 54.3 
ELF1 spp 20528 52.7 
ETS1 spp 2879 72.6 
Ezh2 Scripture 64277 9.9 
GABP spp 5095 79.9 
H2az Scripture 95358 15.0 
H3k27ac Scripture 56069 18.5 
H3k27me3 Scripture 41464 5.4 
H3k36me3 Scripture 33710 3.0 
H3k4me1 Scripture 109612 8.9 
H3k4me2 Scripture 79675 15.3 
H3k4me3 Scripture 57476 17.6 
H3k79me2 Scripture 28302 13.7 
H3k9ac Scripture 41266 25.5 
H3k9me3 Scripture 74515 2.3 
H4k20me1 Scripture 23943 5.0 
JunD spp 1715 3.0 
MAX spp 2087 39.7 
MEF2A spp 16694 11.5 
MEF2C MACS 968 15.1 
NF-E2 MACS 12973 24.2 
NFKB spp 10073 22.1 
NRF1 spp 5042 12.7 
NRSF spp 2541 39.2 
P300 spp 3687 16.5 
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PAX5 spp 19618 18.5 
PBX3 spp 7431 26.1 
POL2 MACS 14989 33.1 
POL3 MACS 112 55.5 
POU2F2 spp 14441 32.9 
PU.1 spp 35821 11.3 
RAD21 MACS 23947 6.5 
RFX5 MACS 26336 33.4 
RXRA spp 2965 31.4 
SIX5 spp 4442 74.8 
SMC3 MACS 64597 14.4 
SP1 spp 13139 46.1 
SRF spp 2412 48.7 
STAT3 MACS 24257 15.1 
TAF1 spp 5169 82.4 
TBP MACS 31315 30.4 
TCF12 spp 15028 25.8 
TR4 MACS 1530 29.5 
USF1 spp 7074 43.0 
USF2 MACS 30248 28.3 
WHIP MACS 88803 17.0 
YY1 MACS 42162 32.3 
ZBTB33 spp 1934 64.8 
ZEB1 spp 8304 46.5 
ZNF143 MACS 81743 18.4 
ZNF274 MACS 1483 1.5 
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Supplementary Table 2.2. Significant overdispersion in peak count among genes is observed for a 
substantial number of GO terms in all 63 ENCODE ChIP-seq datasets from cell line GM12878. Number and 
percentage of GO terms (with 50-500 genes) that contain significant overdispersion in peak counts among the genes 
(q≤0.05). DBPs from Figure 2.1 panels c,f have more peaks than DBPs from panels a, d and thus higher power to 
detect significant overdispersion.  
 
 
  
DBP 
Figure 1 
panel 
# over-
dispersed GO 
terms 
% GO 
 terms over-
dispersed 
 
DBP 
Figure 1 
panel 
# over-
dispersed GO 
terms 
% GO  
terms over-
dispersed 
ATF3 a, d 630 35  PAX5 b, e 1831 100 
cFOS a, d 758 42  POL2 b, e 1828 100 
ETS1 a, d 1253 68  POU2F2 b, e 1827 100 
GABP a, d 1620 88  RAD21 b, e 1755 96 
JunD a, d 692 38  RFX5 b, e 1829 100 
MAX a, d 705 39  SP1 b, e 1829 100 
MEF2C a, d 561 31  STAT3 b, e 1830 100 
NF-E2 a, d 1800 98  TBP b, e 1831 100 
NFKB a, d 1803 98  TCF12 b, e 1828 100 
NRSF a, d 493 27  USF2 b, e 1830 100 
P300 a, d 1413 77  BHLHE40 c, f 1831 100 
PBX3 a, d 1751 96  CHD2 c, f 1832 100 
RXRA a, d 1319 72  CTCF c, f 1831 100 
SIX5 a, d 1448 79  Ctcf c, f 1831 100 
SRF a, d 902 49  EBF1 c, f 1832 100 
TAF1 a, d 1614 88  Ezh2 c, f 1830 100 
TR4 a, d 577 32  H2az c, f 1832 100 
USF1 a, d 1763 96  H3k27ac c, f 1832 100 
ZBTB33 a, d 769 42  H3k27me3 c, f 1831 100 
ZEB1 a, d 1807 99  H3k36me3 c, f 1832 100 
ZNF274 a, d 832 59  H3k4me1 c, f 1832 100 
BATF b, e 1821 99  H3k4me2 c, f 1832 100 
BCL11A b, e 1813 99  H3k4me3 c, f 1832 100 
BCL3 b, e 1826 100  H3k9ac c, f 1832 100 
BCLAF1 b, e 1831 100  H3k9me3 c, f 1832 100 
BRCA1 b, e 1824 100  MXI1 c, f 1832 100 
EGR1 b, e 1825 100  PU1 c, f 1828 100 
ELF1 b, e 1831 100  SMC3 c, f 1831 100 
H3k79me2 b, e 1832 100  WHIP c, f 1832 100 
H4k20me1 b, e 1830 100  YY1 c, f 1832 100 
MEF2A b, e 1815 99  ZNF143 c, f 1832 100 
NRF1 b, e 1829 100      
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Supplementary Table 2.3. GO terms most strongly associated with short locus length. 
The 500 genes with shortest locus lengths (ranging from 23bp to 5,066bp) were tested for GO term enrichment 
relative to all remaining genes (having a computed locus length) using DAVID [39]. 
 
GO Term # genes total genes in term fold enrich p-value q-value 
nucleosome 13 58 11.64 8.0x10
-10
 2.5x10
-7
 
protein-DNA complex 14 81 8.97 4.3x10
-9
 6.6x10
-7
 
translation 25 314 4.10 9.7x10
-9
 1.3x10
-5
 
DNA packaging 14 105 6.87 1.1x10
-7
 7.2x10
-5
 
nucleosome assembly 12 74 8.35 1.6x10
-7
 7.0x10
-5
 
chromatin assembly 12 77 8.03 2.5x10
-7
 8.0x10
-5
 
ribosome 18 201 4.65 3.4x10
-7
 2.6x10
-5
 
protein-DNA complex 
assembly 12 81 7.63 4.2x10
-7
 1.1x10
-4
 
cellular macromolecular 
complex assembly 22 304 3.73 4.6x10
-7
 1x10
-4
 
nucleosome organization 12 83 7.45 5.4x10
-7
 1x10
-4
 
 
 
 
 
Supplementary Table 2.4. GO terms most strongly associated with long locus length.  
The 500 genes with the longest locus lengths (ranging from 879 kb to 15,8 Mb) were tested for GO term enrichment 
relative to all remaining genes (having a computed locus length) using DAVID [39]. 
 
GO Term # genes total genes in term fold enrich p-value q-value 
homophilic cell adhesion 29 130 8.65 1.9x10
-18
 3.9x10
-15
 
nervous system 
development 78 1066 2.84 2.2x10
-17
 2.3x10
-14
 
cell adhesion 60 686 3.39 9.9x10
-17
 7.6x10
-14
 
biological adhesion 60 687 3.39 1.0x10
-16
 5.7x10
-14
 
cell-cell adhesion 37 271 5.30 4.3x10
-16
 1.8x10
-13
 
generation of neurons 43 549 3.04 2.1x10
-10
 4.0x10
-8
 
calcium ion binding 58 896 2.49 2.4x10
-10
 1.4x10
-7
 
neurogenesis 44 591 2.89 6.1x10
-10
 1.1x10
-7
 
neuron differentiation 34 429 3.07 1.9x10
-8
 3.0 x10
-6
 
axonogenesis 21 191 4.26 1.0x10
-7
 1.5x10
-5
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Supplementary Table 2.5a. Top enriched GO terms (not collapsed, with ≤500 genes) for GR ChIP-seq data 
(4,392 peaks) that were significantly enriched (q ≤0.05) using the nearest TSS locus definition.  
Bolded terms are significantly enriched in both ChIP-Enrich and GOseq results. The complete list of enriched GO 
terms for GR using the nearest TSS and ≤1kb from TSS locus definition is included as a supplemental excel file, 
“Supplementary_table_5expanded.csv.” 
a Rank GO term 
nearest TSS 
q-value 
≤1kb from TSS 
q-value 
GOseq 
q-value 
 1 epithelial cell differentiation 1.8x10
-6
 1.0 1.2x10
-6
 
 2 adherens junction 5.3x10
-5
 1.0 0.39 
 3 anchoring junction 5.3x10
-5
 1.0 0.49 
 4 negative regulation of sequence-
specific DNA binding 
transcription factor activity 5.5x10
-5
 1.0 3.0x10
-4
 
 5 anti-apoptosis 5.5x10
-5
 0.34 3.2x10
-9
 
 6 regulation of epithelial cell 
differentiation 7.6x10
-5
 1.0 0.14 
 7 basolateral plasma membrane 1.7x10
-4
 01.0 0.52 
 8 unsaturated fatty acid metabolic 
process 2.9x10
-4 
3.5x10
-3
 0.52 
 9 icosanoid metabolic process 1.8x10
-4
 2.9x10
-3
 4.1x10
-4
 
 10 focal adhesion 4.5x10
-4
 1.0 0.32 
 11 cell-substrate junction 4.5x10
-4
 1.0 0.39 
 12 cell-substrate adherens junction 4.5x10
-4
 1.0 0.35 
 13 regulation of small GTPase mediated 
signal transduction 8.7x10
-4
 1.0 1.3x10
-3
 
 14 response to inorganic substance 1.2x10
-3
 0.075 4.3x10
-4
 
 15 response to growth hormone stimulus 1.4x10
-3
 1.0 1.0 
 16 regulation of cellular component 
movement 1.8x10
-3
 0.74 5.7x10
-6
 
 17 monocarboxylic acid metabolic process 1.9x10
-3
 0.15 0.66 
 18 response to calcium ion 0.0024 0.33 0.14 
 19 regulation of anti-apoptosis 2.9x10
-3
 0.76 0.63 
 20 negative regulation of protein 
metabolic process 3.2 x10
-3
 0.57 5.5 x10
-3
 
 21 response to glucocorticoid stimulus 3.5 x10
-3
 0.56 0.39 
 22 positive regulation of anti-apoptosis 3.7 x10
-3
 0.62 0.49 
 23 response to corticosteroid stimulus 3.9 x10
-3
 0.63 0.18 
 24 regulation of epidermal cell 
differentiation 4.1 x10+ 1.0 0.84 
 25 Ras protein signal transduction 4.1 x10
-3
 1.0 0.26 
 26 energy reserve metabolic process 4.2 x10
-3
 1.0 0.60 
 27 negative regulation of transcription 
from RNA polymerase II 
promoter 4.4 x10
-3
 1.0 2.5x10
-6
 
 28 actin cytoskeleton organization 4.4 x10
-3
 1.0 0.15 
 29 vasculature development 4.7 x10
-3
 0.97 7.4x10
-16
 
 30 small GTPase mediated signal 
transduction 4.7 x10
-3
 1.0 4.9 x10
-3
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Supplementary Table 2.5b. Top enriched GO terms (not collapsed, with ≤500 genes) for GR ChIP-seq data 
(4,392 peaks) that were significantly enriched (q ≤0.05) using the ≤1kb from TSS locus definition. Bolded terms 
are significantly enriched in both ChIP-Enrich and GOseq results. The complete list of enriched GO terms for GR 
using the nearest TSS and ≤1kb from TSS locus definition is included as a supplemental excel file, 
“Supplementary_table_5expanded.csv.” 
b Rank GO term 
≤1kb from TSS 
q-value 
nearest TSS 
q-value 
GOseq 
q-value 
 1 negative regulation of blood 
coagulation 3.2x10
-7
 0.077 0.010 
 2 negative regulation of coagulation 4.3x10
-7
 0.15 0.015 
 3 fibrinolysis 3.5x10
-5
 0.088 0.033 
 4 regulation of blood coagulation 7.0x10
-5
 0.011 5.4x10
-4
 
 5 regulation of fibrinolysis 1.4x10
-4
 0.073 0.11 
 6 regulation of coagulation 1.4x10
-4
 0.029 9.9x10
-4
 
 7 intrinsic to external side of plasma 
membrane 1.8x10
-4
 0.062 0.68 
 8 leukotriene metabolic process 2.2x10
-4
 6.3x10
-3
 1.0 
 9 positive regulation of coagulation 3.1x10
-3
 0.061 0.028 
 10 anchored to plasma membrane 2.1x10
-3
 0.39 1.0 
 11 regulation of wound healing 2.9x10
-3
 6.4x10
-3
 1.4X10
-4
 
 12 regulation of response to external 
stimulus 2.9x10
-3
 0.014 5.0X10
-5
 
 13 positive regulation of coagulation 3.0x10
-3
 0.061 0.028 
 14 positive regulation of leukocyte 
chemotaxis 3.5 x10
-3
 0.092 0.017 
 15 platelet alpha granule lumen 4.7 x10
-3
 0.25 0.61 
 16 secretory granule lumen 4.7 x10
-3
 0.29 0.63 
 17 cytoplasmic membrane-bounded 
vesicle lumen 5.1 x10
-3
 0.25 0.64 
 18 ameboidal cell migration 5.2 x10
-3
 0.31 0.94 
 19 regulation of nuclease activity 5.2 x10
-3
 0.083 0.66 
 20 cellular response to biotic stimulus 5.2x10
-3
 6.1x10
-3
 3.7x10
-3
 
 21 vesicle lumen 5.5 x10
-3
 0.20 0.68 
 22 nucleotide-binding domain, leucine rich 
repeat containing receptor 
signaling pathway 6.1 x10
-3
 0.15 0.32 
 23 peptidyl-glutamic acid carboxylation 6.9 x10
-3
 0.11 1.0 
 24 regulation of leukocyte chemotaxis 0.011 0.18 0.028 
 25 long-chain fatty acid transport 0.011 0.028 0.12 
 
26 
second-messenger-mediated 
signaling 0.012 0.66 0.047 
 27 positive regulation of leukocyte 
migration 0.014 0.20 0.031 
 28 carboxylic acid transport 0.014 0.18 0.39 
 29 external side of plasma membrane 0.015 0.63 1.0 
 30 endoplasmic reticulum unfolded protein 
response 0.069 0.015 0.29 
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 RNA-Enrich: A cut-off free functional enrichment Chapter 3
testing method for RNA-seq with improved detection power 
3.1 Introduction  
Functional enrichment testing is one of the most common downstream analyses 
for transcriptomics experiments, facilitating a deeper interpretation of results. Examples 
of gene set databases used for testing are Gene Ontology (GO) which includes 
biological processes, cellular components, and molecular functions, and the Kyoto 
Encyclopedia of Genes and Genomes (KEGG) which places genes in metabolic and 
other pathways. Most current gene set enrichment (GSE) methods, such as DAVID [66], 
were developed for microarray data. These methods often only make use of differential 
expression (DE) p-values or ranks, or simply a list of significant genes. With RNA-seq, 
which uses whole transcriptome sequencing to quantify gene expression, tests for DE 
often exhibit a relationship between read count and likelihood of detecting DE. For 
example, when power is greater to detect longer and/or higher expressed genes, gene 
sets that have long genes or that are highly expressed are more likely to be detected as 
significant, violating common test assumptions. Thus, accounting for read count per 
gene may improve standard GSE methods, which may otherwise not be appropriate for 
RNA-seq data. 
RNA-seq achieves a very high dynamic range, with gene read counts often 
varying across six or more orders of magnitude. Read-count based methods such as 
those using a negative binomial model (e.g., edgeR and DEseq2) can be more likely to 
identify longer and highly-expressed transcripts as significant. Two methods that can 
account for this bias in GSE testing are GOseq [9] which requires a p-value cut-off, and 
Chapter 3 is published as Lee C, Patil S, Sartor MA: RNA-Enrich: a cut-off free functional enrichment testing 
method for RNA-seq with improved detection power. Bioinformatics 2015. 
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GSAASeqSP [32] and SeqGSEA[33], which require permutations and moderate to large 
sample sizes to obtain a sufficient number of unique permutations of phenotype labels. 
We have developed RNA-Enrich, a GSE method that empirically adjusts for average 
read count per gene, and does not require a cut-off to define differentially expressed 
genes (DEGs), time consuming permutations, or regression models. Similar cut-off free 
methods for microarray data have shown improved ability to detect gene sets enriched 
with either a few very strong DEGs or many only moderate DEGs [35, 36].  
3.2 Methods 
3.2.1 Model 
RNA-Enrich models the relationship between log10(average read count) per gene 
and -log10(significance score) using a binomial cubic smoothing spline. The significance 
scores, usually p-values, and read counts are input by the user. Per gene weights (wg) 
are calculated from the spline fit as the ratio between mean –log10(p-value) and fitted 
values, and then normalized to have a mean of 1. A modified version of the random sets 
method, as proposed by [34], is used. We calculate the test statistic ?̅? for genes in a 
gene set: 
)*( gg swmeanx     (1) 
where sg is the –log10(p-value) from a differential gene expression test such as edgeR 
or DESeq2. The distribution of the statistic to test whether ?̅? is significantly different from 
what is expected by chance is intractable. Instead, we use the first and second 
moments of the distribution to define approximate z-scores which are then used to 
calculate p-values of enrichment [34]. Adjusted p-values (q-values) are calculated to 
correct for multiple testing.  
The use of weights ensures that if a relationship exists between read count and 
DE p-values genes, it will be adjusted for properly. The original random sets method 
does not include the wg terms, i.e. all genes are equally weighted; the method for 
calculating p-values using approximate z-scores was the same. Our website supports 
16 different annotation databases plus custom gene sets, seven organisms, and 
clustering of results. 
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3.2.2 Datasets 
Prostate cancer LNCaP cells treated with an androgen hormone 
Li, et al [90] collected RNA-seq data from LNCaP cells, a prostate cancer model 
cell line, treated with an androgen hormone, which is associated with survival in 
prostate cancer. There were 7 total samples: 3 replicates treated with 100μM of 
dihydrotestosterone (DHT) to stimulate androgen production, and 4 controls treated with 
an inactive compound. Expression data was downloaded from 
http://yeolab.ucsd.edu/yeolab/Papers; and differential gene expression testing was 
performed using edgeR accounting for tag-wise overdispersion using R code provided 
by [91] in the edgeR user’s guide on Bioconductor, and with DESeq2 ([92]).  
A549 cells treated with dexamethasone 
The ENCODE dataset, wgEncodeHaibRnaSeqA549Dex100nm, consists of 4 
total samples from A549 cells, adenocarcinomic human alveolar basal epithelial cells: 2 
replicates treated with 100μM of dexamethasone (DEX) and 2 controls treated with 
0.02% ethanol solution. We performed differential gene expression testing using edgeR 
accounting for tag-wise overdispersion and with DESeq2. 
Tunicamycin-treated mice embryonic fibroblasts 
Embryonic fibroblasts from transgenic mice [93] were treated with tunicamycin for 
10 hours. Two treated samples were compared to two controls. Expression data was 
downloaded from GEO (ascension number GSE35681). We performed differential gene 
expression testing using edgeR accounting for tag-wise overdispersion and with 
DESeq2. 
3.2.3 Description of Permutations 
We performed two sets of permutations: “permuted within bins” and “permuted 
overall.” Permuted data was then tested for enrichment of Gene Ontology (GO) terms. 
When data was permuted within bins, the input data, which includes three columns: 
gene ID, differential gene expression p-value and the read count, is ordered by read 
count and divided into bins of 100 genes. Per each group of 100 genes, p-value and 
read count is randomized. This permutation scenario preserves any relationship 
between read count and p-values but removes any association between p-values and 
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GO term membership. In the second permutation scenario, p-values and read counts 
were randomized over all genes, which removes their relationship as well as any 
association between p-values and GO term membership. The difference between the 
results of these two permutations is due to the effect of the relationship between read 
counts and significance values. For example, in the barplots, if a method is conservative 
for “permuted overall” but has an excess of p-values in the left-most bar for “permuted 
within bins”, then that method is not adequately adjusting for the relationship between p-
values and read count. 
For each dataset, we created 100 permuted datasets for each permutation 
scenario. The median p-value of each GO term was calculated across all permutations 
in a permutation scenario for each dataset. We tested each dataset with RNA-Enrich, 
random sets, GOseq, and DAVID.  
3.2.4 Performance Comparison 
To assess the type I error rate for RNA-Enrich, we created permuted datasets 
from two experiments. The first, prostate cancer LNCaP cells treated with 
dihydrotestosterone (DHT), an androgen hormone [90], showed increasing read counts 
with increasing significance (Figure 3.1a). The second, A549 cells treated with 
dexamethasone (ENCODE dataset wgEncodeHaibRnaSeqA549Dex100nm) showed 
steady read counts with increasing significance (Figure 3.1d).  
The original datasets were sorted by read counts, and then within each bin of 
100 genes, GO term membership, DE p-value and average read count were permuted 
as a group. This scenario preserved the association between p-values and read count 
but removed functional enrichment significance from the data, allowing us to assess 
type I error under the null hypothesis and given the observed relationship with read 
count. We also tested the use of corrected fold changes instead of p-values; in this case 
the relationship with read count differed by dataset, but still existed. For both the LNCaP 
dataset and the A549 dataset, 100 permutations were performed. Each original dataset 
and permutation was tested using RNA-Enrich, the random sets method, GOseq and 
DAVID for all GO terms containing 10 – 500 genes. The median p-value of each GO 
term was calculated across all permutations for each dataset. We also provide results 
for a simpler type of permutations, where data was permuted over all genes; this does 
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not preserve the association between DE p-values and read count, and is thus an 
estimate of what type I error would be if no relationship with read count existed. 
3.2.5 Other comparisons 
We used GOseq version 1.18.0 on R version 3.1.1 for enrichment testing on the 
original datasets and the permuted datasets. Average normalized read counts were 
provided as the bias data. We tested the original and the permuted datasets using both 
the sampling method and Wallenius approximation [9]. 
We reimplemented DAVID [39], which uses a modified Fisher’s exact test, to use 
in R in order to test the same GO database that was tested with RNA-Enrich, the 
random sets method, and GOseq.  
We calculated a corrected fold change (cFC) = log2( (X+C) / (Y+C)) where C = 
10th percentile of read counts, X is the average normalized read count per gene for 
treatment cases, and Y is the average normalized read count per gene for control 
cases. Each sample’s read counts were normalized for library size by dividing by total 
number of reads of sample, and then multiplied by average read count across all 
samples. cFC was used in place of –log10(p-value) in RNA-Enrich and random sets. 
3.3 Results & Discussion 
3.3.1 Method performance with permutated data 
Using permuted datasets we compared the type I error of RNA-Enrich to the 
random sets method (does not account for any bias in the data), GOseq (can adjust for 
read counts, but using a cut-off based method), and DAVID (does not adjust for read 
counts, and uses a cut-off based method). We show that when there is a relationship 
between read count and –log10(p-values), adjusting for read count improves the type I 
error rate compared to random sets (Figure 3.1a-c and Figure 3.2). Without adjusting for 
read count, 37 GO terms were enriched in the permuted data for random sets but only 3 
for RNA-Enrich (q-value≤0.05). When the relationship does not exist, as is observed in 
the A549 dataset, RNA-Enrich and random sets have nearly identical type I error rates 
(Figure 3.1d-f). DAVID had 0 GO terms enriched in the permuted data for the LNCap 
experiment, but its type I error was overly conservative in cases where no relationship 
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exists (Figure 3.3). RNA-Enrich provides a diagnostic plot for the user to determine if a 
relationship between read count and –log10(p-value) exists in their data (Figure 3.1a,d). 
If a relationship does exist, we recommend using RNA-Enrich to provide more 
biologically relevant results. RNA-Enrich also has favorable type I error rate compared 
to GOseq and DAVID (Figure 3.3, Figure 3.4, Figure 3.5). The performance of RNA-
Enrich with p-values from DESeq2 instead of edgeR resulted in the same conclusions 
(Figure 3.6). Use of corrected fold change instead of p-values as input showed a 
different relationship exists, but similarly resulted in a benefit for RNA-Enrich compared 
to random sets (Figure 3.7). 
3.3.2 Method performance with experimental results 
Using RNA-Enrich with the LNCaP cells treated with DHT we found 192 enriched 
GO terms (q-value ≤0.05) (Table 3.1 and Supplementary Table 3.1). In comparison, the 
random sets, GOseq, and DAVID methods identified 35, 8, and 30 enriched GO terms, 
respectively. We tested a second dataset, mice embryonic fibroblasts treated with 
tunicamycin, that also revealed a relationship between read counts and significance 
levels, and resulted in conclusions similar to the LNCaP dataset (Figure 3.8, Figure 3.9, 
Figure 3.10). Again, RNA-Enrich detected more GO terms than the alternatives (Figure 
3.8). 
In the A549 dataset, we did not expect an advantage to RNA-Enrich over random 
sets, since there was no observed relationship between read count and significance 
levels. RNA-Enrich found 367 enriched GO terms including negative regulation of 
transcription, vasculature development and fat cell differentiation – all top ranked 
enriched GO terms also found by random sets and GOseq. Random sets and GOseq 
identified 347 and 363 GO terms, respectively. Based on Figure 3.1e,f and our overall 
findings, RNA-Enrich has the desirable property of reducing to the random sets method 
when no relationship with read count exists. 
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3.4 Figures and Tables 
 
 
Figure 3.1. Comparison of RNA-Enrich with random sets with two datasets exhibiting two different p-value to 
average read count trends. Permuted data is “permuted within bins.” (a) RNA-seq data from LNCaP cells treated 
with DHT compared to a control showed a relationship between average gene read count and –log10(p-values) from 
DE tests. (b-c) Histogram of permutation p-values (teal color) should be uniformly distributed for acceptable type I 
error rate. For RNA-Enrich, the type I error rate is approximately uniform (b), but for the random sets approach for 
which there is no correction, more p-values are significant than expected (c). With the original data, RNA-Enrich 
identifies more significant GO terms than the random sets method (pink color). (d) RNA-seq data from A549 cells 
treated with Dex compared to ethanol showed no relationship between read count and –log10(p-values). (e-f) With or 
without the read count bias correction, type I error rate is approximately uniform, indicating that no correction is 
needed and either test is valid. 
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RNA-Enrich Random Sets 
Prostate cancer LNCaP cells treated with an androgen hormone 
a 
Permuted within bins 
 
P-value 
b 
Permuted overall 
 
P-value 
c 
Permuted within bins 
 
P-value 
d 
Permuted overall 
 
P-value 
A549 cells treated with dexamethasone 
e 
Permuted within bins 
 
P-value 
f 
Permuted overall 
 
P-value 
g 
Permuted within bins 
 
P-value 
h 
Permuted overall 
 
P-value 
Tunicamycin-treated mice embryonic fibroblasts 
i 
Permuted within bins 
 
P-value 
j 
Permuted overall 
 
P-value 
k 
Permuted within bins 
 
P-value 
l 
Permuted overall 
 
P-value 
 
Figure 3.2. RNA-Enrich and random sets performance on permutated data. P-value distributions of RNA-Enrich 
versus the random sets method on datasets that were “permuted within bins” and “permuted overall.” Histograms of 
permutation p-values (teal color) should be uniformly distributed for acceptable type I error rate. Both the prostate 
cancer LNCaP dataset (a-d) and a third dataset of tunicamycin-treated mice embryonic fibroblasts (i-l) exhibited a 
positive relationship between read count and DE p-values. When enrichment testing was applied to the permuted 
datasets that were permuted within bins, which preserves that relationship, RNA-Enrich had a better type I error rate 
than the random sets method, which shows an excess of low p-values when data is permuted within bins (c,k). When 
data is permuted overall (b,d,f,h,j,l), the type I error of RNA-Enrich and random sets is similar, which implies that the 
difference between methods observed for the “permuted within bins” scenario is due to random sets’ inability to adjust 
for the effect of read counts. RNA-Enrich calls more significantly enriched gene sets than random sets for this 
dataset. When RNA-Enrich and random sets were applied to the A549 cells dataset, type I error was very similar 
between the two methods and both methods called a similar number and list of enriched gene sets. 
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Top 500 genes (p ≤ 5.36 x10-14, q ≤ 1.46 x10-12) 
a permuted within bins 
 
b permuted overall 
 
Top 1000 genes (p ≤ 7.13 x10-7, q ≤ 9.65 x10-7) 
c permuted within bins 
 
d permuted overall 
 
Genes with p ≤10-4 (1,934 genes, q ≤ 6.94 x10-4) 
e permuted overall 
 
f permuted overall 
 
 
Figure 3.3. DAVID results: Prostate cancer LNCaP cells treated with an androgen hormone. P-value 
distributions from DAVID with the LNCaP dataset. Histograms of permutation p-values (teal color) should be 
uniformly distributed for acceptable type I error rate. (a, c, e) When the permuted data retains the relationship 
between read counts and DE p-values, DAVID calls more significantly enriched GO terms when the cutoff for 
differential expression includes more genes. (b, d, f) When the permuted data no longer has a relationship 
between read counts and DE p-values, the type I error rate of DAVID is conservative. 
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Top 500 genes (p ≤ 0.88, q ≤ 1) 
a permuted within bins 
 
b permuted overall 
 
 
Top 1000 genes (p ≤ 0.83, q ≤ 1) 
c permuted within bins 
 
d permuted overall 
 
 
Genes with p ≤10-4 (156 genes, q ≤ 0.01) 
e permuted within bins 
 
f permuted overall 
 
 
Figure 3.4. DAVID results: A549 cells treated with dexamethasone. P-value distributions from DAVID with the 
A549 cells dataset. Histograms of permutation p-values (teal color) should be uniformly distributed for acceptable 
type I error rate. (a-f) The type 1 error rate for DAVID is similar when testing on data permuted within bins (retains 
relationship between read count and DE p-values) and permuted overall (relationship is not retained), because this 
data set does not have a relationship between read count and differential gene expression p-values. The type I error 
rate of DAVID is somewhat conservative. 
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RNA-Enrich 
a permuted within bins 
 
P-value 
b permuted overall 
 
P-value 
 
GOSeq, sampling, 500 genes (p ≤ 5.36 x10-14, q ≤ 1.46 x10-12) 
c permuted within bins 
 
P-value 
d permuted overall 
 
P-value 
 
GOSeq, Wallenius, 500 genes (p ≤ 5.36 x10-14, q ≤ 1.46 x10-12) 
e permuted within bins 
 
P-value 
f permuted overall 
 
P-value 
 
 
Figure continues on next page…  
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GOSeq, sampling, with p ≤10-4 (1,934 genes, q ≤ 6.94 x10-4) 
g permuted within bins 
 
P-value 
  
GOSeq, Wallenius, with p ≤10-4 (1,934 genes, q ≤ 6.94 x10-4) 
h permuted within bins 
 
P-value 
  
 
Figure 3.5. RNA-Enrich vs GOseq: Prostate cancer LNCaP cells treated with an androgen hormone. 
RNA-Enrich versus GOseq for LNCaP dataset. Histograms of permutation p-values (teal color) should be 
uniformly distributed for acceptable type I error rate. For the GOseq analysis, we used two different cut-offs to 
define differentially expressed genes: the top 500 significant genes, and genes with p-value ≤10
-4
. We tested 
GOseq using both the default sampling method as well as the Wallenius approximation method. (a-b) For RNA-
Enrich, the type I error rate is approximately uniform. (c-d) GOseq using the sampling method and a cutoff of 
the top 500 genes to define differentially expressed genes, results in an approximately uniform distribution. 
(a,b) With the original data, RNA-Enrich identifies more significant GO terms than GOseq (pink color). (e,f) 
GOseq using the Wallenius approximation and a cutoff of the top 500 genes to define differentially expressed 
genes. Again, the type I error rate is acceptable. (g) GOseq using the sampling method and genes with p- value 
≤10
-4
. (h) GOseq using the Wallenius approximation and genes with p- value ≤10
-4
. (d,f) Type I error of RNA-
Enrich and GOseq using permuted data that was permuted overall, which removes any relationship between 
read count and differential gene expression p-values, was similar to that using the data that was permuted 
within bins. This suggests both methods do account for that bias. However, all cutoffs we tried with GOseq 
resulted in less significant GO terms than with RNA-Enrich.  
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Prostate cancer LNCaP cells treated with an androgen hormone 
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Figure 3.6. Comparison of RNA-Enrich and Random Sets using DESeq2 differential gene expression 
significance values. Relationships between read counts and significance values, and p-value distributions for 
RNA-Enrich and random sets using p-values from DESeq2 instead of edgeR. Results were similar between the 
two differential gene expression tests. (a,d) Relationship between read count and differential gene expression p-
values remain the same for each dataset as they appeared for edgeR. (b,e; teal color) Type I error of RNA-Enrich 
remains improved over (c,f; teal color) random sets when there exists a relationship between read count and DE 
p-value (b,c) and is the same when there is no relationship (e,f). RNA-Enrich still appears to have improved 
detection power (b,c,e,f; pink color). 
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androgen hormone 
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Figure 3.7. Comparison of RNA-Enrich and Random Sets using corrected fold change as significance 
values. Results for RNA-Enrich and random sets using corrected fold change (cFC) = log( (X+C) / (Y+C)) where 
C = 10
th
 percentile of read counts, X is average normalized read count per gene for treatment cases, and Y is 
average normalized read count per gene for control cases. (a,e) Relationship between read counts and cFC 
exists for A549 dataset, but not for the LNCaP dataset, which is opposite from what was observed based on p-
values. Permutation p-value distributions for RNA-Enrich (b,f; teal color) compared to random sets (c,g; teal color) 
show that random sets has more lower p-values than expected for the A549 dataset, as evident in the higher bar 
at p=0 – 0.02. (d,h) GSE –log10(p-values) were highly correlated between RNA-Enrich using cFC and RNA-Enrich 
using p-values from edgeR.  
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Figure 3.8. RNA-Enrich vs random sets in tunicamycin-treated mouse embryonic fibroblasts dataset using 
edgeR. (a) RNA-seq data from tunicamycin-treated mouse embryonic fibroblasts also showed a relationship between 
average gene read count and –log10(p-values) from differential expression tests using edgeR. (b-e) Histograms of 
permutation p-values (teal color) should be uniformly distributed for acceptable type I error rate. (b) For RNA-Enrich, 
the type I error rate is again approximately uniform. (c) For the random sets approach for which there is no correction, 
more p-values are significant than expected. With the original data, RNA-Enrich identified more significant GO terms 
(548) than the random sets method (310) (pink color). (d) Using GOseq (sampling method) and a cutoff of q≤10
-4
 
(795 genes) to define differentially expressed genes, 158 GO terms were enriched. (e) Using DAVID with the top 
1,000 genes (p ≤ 4.44 x10-5, q ≤ 7.80 x10-4), 274 GO terms were enriched. 
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Figure 3.9. RNA-Enrich vs random sets in tunicamycin-treated mouse embryonic fibroblasts dataset using 
DEseq2. (a) RNA-seq data from tunicamycin-treated mouse embryonic fibroblasts also showed a relationship 
between average gene read count and –log10(p-values) from differential expression tests using DEseq2. (b-c) 
Histograms of permutation p-values (teal color) should be uniformly distributed for acceptable type I error rate. (b) For 
RNA-Enrich, the type I error rate is again approximately uniform. (c) For the random sets approach for which there is 
no correction, more p-values are significant than expected. With the original data, RNA-Enrich identified more 
significant GO terms (771) than the random sets method (415) (pink color).  
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Figure 3.10. RNA-Enrich vs random sets in tunicamycin-treated mouse embryonic fibroblasts dataset using 
corrected fold change. (a) RNA-seq data from tunicamycin-treated mouse embryonic fibroblasts showed only a very 
slight relationship between average gene read count and cFC. (b-c) Histograms of permutation p-values (teal color) 
should be uniformly distributed for acceptable type I error rate. (b) For RNA-Enrich, the type I error rate is again 
approximately uniform. (c) For the random sets approach for which there is no correction, only slightly more p-values 
are significant than expected. In this case with the original data, RNA-Enrich identified 758 significant GO terms and 
the random sets method identified 842 GO terms as significant (pink color).  
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Table 3.1. Top ranked GO terms from RNA-Enrich for LNCaP cell line treated with DHT.  
Results shown are limited to the top unrelated GO terms. 
Rank GO term P-value FDR 
 1 extracellular space 2.3 x 10-8 1.6 x 10-6 
 2 vasculature development 4.6 x 10-9 3.4 x 10-6 
 7 signaling receptor activity 3.9 x 10-7 1.3 x 10-4 
 9 epithelial cell differentiation 2.3 x 10-6 5.0 x 10-4 
 10 cellular biogenic amine metabolic process 2.4 x 10-6 5.0 x 10-4 
 12 response to endoplasmic reticulum stress 8.9 x 10-6 1.3 x 10-3 
 
 
Supplementary Table 3.1. Extended version of Table 3.1.  
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 Transposons, segmental duplications, sequence Chapter 4
mappability, and gene length: Deciphering their relationship 
with gene function 
4.1 Introduction 
The ability to uniquely map short DNA read sequences to a reference genome 
(referred to as mappability) varies significantly across the mammalian genome [88, 94], 
with repetitive and duplicated regions generally reducing mappability. Mappability tracks 
are available on the UCSC Genome Browser for the human and mouse genomes [88] 
and some peak finders for the discovery of DNA binding sites in ChIP-seq data, such as 
PeakSeq [88], MOSAICS [18] and MUSIC [95], can adjust for mappability when calling 
peaks. Others have noted read bias in copy number variation calls due to mappability 
and have proposed methods to adjust for this [96]. Although mappability is a technical 
factor, it can serve as a measure of sequence uniqueness for any genomic region of 
interest, and may help to reveal the underlying regulatory architecture of the functional 
genome.  
While mappability has not yet been studied in conjunction with gene function, 
there are several studies that suggest genes requiring more complex and tissue-specific 
regulation have at least some regions with high mappability, and vice versa. The 
creators of the CRG mappability tracks, which we utilize in this study, found that the 
approximately 900 olfactory receptor genes annotated in GENCODE were 10% less 
mappable than the average of protein-coding genes [94]. Olfactory receptor genes are 
highly paralogous. The majority of them in humans are no longer functional but are 
pseudogenes, and many have multiple copies [97], resulting in lower mappability. On 
the other end of the mappability spectrum, transposon-free regions are long stretches of 
sequence that are devoid of transposons (a class of repetitive elements), and therefore 
are more likely to be highly mappable. Though exons have a higher proportion of 
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transposon-free regions, the majority of transposon-free regions occur in intronic and 
intergenic regions. The longest transposon-free regions are enriched in or near genes 
involved in DNA binding, regulation of transcription and development [21]. The 
distribution of transposon-free regions and their functional annotation suggest that 
certain genes need more finely tuned regulation, while other genes, such as olfactory 
receptor genes, do not need as finely tuned regulation and are more tolerant of 
repetitive element insertion, mutations, and may gain/lose copies over time.  
Evolutionarily, the cell can fine-tune gene regulation by (1) having more potential 
regulatory space around the gene exons (i.e. longer intergenic distances and/or longer 
introns), (2) having more unique sequence space (e.g. fewer repetitive elements), or (3) 
both. Nelson et al. [98] have shown these two properties are related to regulatory 
complexity in Drosophila melanogaster and Caenorhabditis elegans. We hypothesize 
that in mammals, mappability, along with gene and intergenic length, can be used as an 
indirect measure of the complexity of a gene’s regulation. Although mappability has 
been shown to bias read coverage and the results of multiple sequencing applications, 
little has been published on the relationship between mappability and gene function in 
mammals. To study this relationship, one needs to consider the main factors that 
contribute to mappability: transposons and segmental duplications. 
Repetitive elements, such as transposons and segmental duplications, pose a 
major problem to sequence alignment. Transposons such as long interspersed nuclear 
elements (LINEs), short interspersed nuclear elements (SINEs) , long terminal repeats 
(LTRs), and DNA transposons (transposons that do not require an RNA intermediate) 
together constitute an estimated 45% of the human genome [20, 21] (and possibly up to 
66% [99]) . These regions have a high level of short sequence repeats and tend to be 
poorly mappable, although their mappability is correlated with age since older 
transposons have had more time to accumulate mutations. LINEs and SINEs are 
classes of autonomous mobile DNA sequences. Both LINEs and SINEs primarily move 
in a “copy and paste” manner using reverse transcriptase to insert DNA copies into the 
genome, however SINEs do not encode the reverse transcription machinery and rely 
upon reverse transcriptase produced from intact LINEs. LINEs and SINEs have been 
evolutionarily selected against in coding regions such as exons, but make up a large 
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proportion of non-coding DNA, which include promoters, introns, and intergenic regions 
[100]. In the human genome, the most abundant transposons in the LINE and SINE 
classes are LINE-1 (L1) elements and Alu elements, respectively. L1 elements make up 
an estimated 15% of the human genome, while Alu elements make up an estimated 
11% and are twice as abundant as L1 elements [22, 100, 101]. The Alu sequence is 
only 300bp, while the canonical L1 sequence is 6kb in length, however the majority of 
L1 elements in the genome are fragments of the original. Alu elements are more often 
observed in gene-rich regions, while L1s are enriched in gene-poor regions. 
Consequently, Alu elements are also enriched in R-bands (euchromatin) and CpG rich 
regions. However, Alu elements are more likely to be evolutionarily selected against 
over time compared to L1 elements [22].  
Segmental duplications are long duplications of DNA sequence, inter- and intra- 
chromosomal, that are 1-200kb in length and have >90% identity. They make up about 
5% of the human genome [102-105] and are enriched near centromeres and telomeres, 
as well as specific focal regions within euchromatin. It is estimated that 10.6% of highly 
identical (>98% identity) segmental duplications are paralogs, genes related by 
duplication that may evolve to have new functions [102]. Indeed segmental duplications 
have been implicated as the source of evolution of novel genes [106, 107], including 
genes that contributed to the divergence between humans and apes [108, 109].  
While the distribution of repetitive elements and segmental duplications across 
the human genome is well-characterized, studies of their relationship with gene function 
have been limited. Alu elements have been shown to have a preference for (or are 
tolerated in) promoter regions of housekeeping genes over tissue-specific genes [110], 
and canresult in new binding sites for multiple transcription factors with single nucleotide 
mutations [111, 112]. An analysis of Alu distribution in chromosomes 21 and 22showed 
that Alu elements on these chromosomes were enriched in or near transport, 
metabolism, and signaling genes [113]. A recent study of L1 elements in coding regions 
found that these genes produced proteins such as transcriptional factors, and 
topoisomerase, and were involved in histone modification, RNA elongation, signal 
transduction, membrane receptors and extracellular growth factors [114]. L1 elements in 
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intergenic regions have been suggested to help recruit the protein Xist RNA for X-
inactivation [115].  
Despite the above specific studies, to our knowledge, a genome-wide analysis of 
repetitive elements and segmental duplications and their relationship with gene function 
has not been conducted. One reason why this may not yet have been accomplished is 
that until recently, there was no functional enrichment testing method developed to 
handle data with these characteristics that have extremely high prevalence across the 
genome in both genic and intergenic regions. However, given an appropriate 
enrichment testing method, genome-wide functional enrichment of repetitive element 
families could elucidate evolutionary selection pressures, and identify which gene 
functions may benefit from maintaining or deleting repeats in the various regulatory 
regions of the associated genes. 
Although little is known about the relationship between repetitive element families 
and gene function, the relationship between gene function and the length of a gene or 
the amount of intergenic distance surrounding a gene has been well-studied [38-40]. 
For example, genes involved in various developmental programs, nervous system 
related processes, and regulation of transcription (as determined by Gene Ontology 
(GO)) tend to be longer and/or have longer intergenic distances surrounding them. 
Conversely, genes involved in electron transport, chromatin assembly and organization, 
and the ribosome and rRNA processing tend to be shorter and/or have shorter 
intergenic distances.  
Since repetitive elements and segmental duplications are the main contributors 
to mappability, we reasoned that if they are all independently depleted in the same gene 
functions as intergenic distance, it would be strong evidence that natural selection 
pressure drives these same gene functions to have overall higher levels of unique, 
potential regulatory sequence. We hypothesized that some or all of the gene functions 
that require complex regulation, also require a high level of uniqueness in the 
surrounding sequences. This would result in higher than average mappability levels and 
maintenance of long gene locus length that would provide protection from degradation 
of essential DNA sequence or distances for DNA loops. This leads to the hypothesis 
that genes with fewer transposons and segmental duplications in their surrounding 
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regions, and with longer intronic/intergenic regions, require complex regulation. 
Conversely, we hypothesize that genes containing more transposons and segmental 
duplications require simpler regulation and/or may have adapted the repetitive elements 
for their own regulatory purposes. 
Here we examine the levels of L1 elements, Alu elements, segmental 
duplications, and overall mappability in different genic and intergenic regions, as well as 
gene length, to discern significant patterns of enrichment or depletion across gene 
functions. We first show how average mappabiilty differs among gene locus regions 
(e.g. exons, introns, promoters). Secondly, we characterize the contribution of L1, Alu, 
and other repetitive elements, and segmental duplications to mappability across various 
regions in the human genome. We illustrate a strong relationship between repetitive 
elements and gene function and compare that with those of gene length and 
mappability. Our results suggest mappability could have important implications for 
interpretation of deep sequencing applications, and the evolutionary mechanisms used 
to achieve proper regulation. 
4.2 Methods 
4.2.1 Locus regions 
We define the locus regions similarly to those in Welch and Lee, et al [116]. The 
TSS extended locus region is defined as the genomic region between the upstream and 
downstream midpoints between a gene and the TSS’s of the two adjacent genes. This 
region represents an estimate of the entire region that is part of, or regulates, the gene. 
≤5kb from TSS is defined as the region within 5kb upstream and downstream of all 
TSSs in a gene. If TSSs from the adjacent gene(s) are less than 10kb away, we use the 
midpoint between the two TSSs as the boundary of the locus for each gene. We define 
>5kb upstream from TSS as the region between 5kb upstream of a TSS to the midpoint 
of the adjacent upstream TSS. We also defined two additional locus regions: exons, the 
exonic regions of each gene (in the case where exons from multiple transcripts of the 
same gene overlap, the region was reduced to one non-overlapping region), and 
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introns, the intronic regions of each gene, that is the region between two non-
overlapping exons of transcripts belonging to the same gene.  
4.2.2 Mappability calculations 
We calculated base pair mappability for reads of lengths 24, 36, 50, 75, and 100 
base pairs derived from mappability data for Homo sapiens (build hg19) from the CRG 
mappability tracks on the UCSC Genome Browser [94]. An illustration of our mappability 
calculations is shown in Figure 4.1. Let Bi be the average read mappability of all 
possible reads of size K that encompass a specific base pair location, i, based on the 
mappability tracks from the UCSC browser. The values from the UCSC mappability 
tracks are the reciprocal of the number of mapped locations in the genome to which a 
read beginning at position j and extending for length K maps uniquely. A value of 1 
indicates the read maps to one location in the genome. A value of 1/n indicates the read 
maps to n distinct places in the genome. We converted the values from the mappability 
track to binary (either uniquely mappable or not). For each base pair position, and then 
determined the proportion of reads overlapping that position that are uniquely 
mappable. We defined the mappability of a locus as the average of all base pair 
mappability values in the defined gene locus region. We chose to primarily use 50mer 
read length throughout the chapter due to the common choice of this read length, 
especially for ChIP-seq experiments. 
4.2.3 Repetitive elements and segmental duplications 
We defined repetitive elements using the repeat masker (“rmsk”) and segmental 
duplications (“superdupe”) tables from the UCSC genome browser. For Alu and L1 
elements, we used the subset of the repeat masker table defined by the respective 
transposon family. Mappability of each non-overlapping region was calculated in the 
same way as locus definitions; that is, we averaged base pair mappability over the 
repetitive element or segmental duplication. 
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4.2.4 Contribution of repetitive elements and segmental duplications to 
mappability 
To quantitate the contribution of each repeat type to mappability, we created a 
contribution score for each repeat type, C, which we define as 1 minus the mappability 
of the region where the repeat type overlapped with the loci, multiplied by the percent of 
the loci covered by the repeat type. We performed simple linear regression using the 
model: 
𝑚𝑎𝑝𝑝𝑎𝑏𝑖𝑙𝑖𝑡𝑦 = 𝛽1𝐶𝐴𝑙𝑢 + 𝛽2𝐶𝐿1 + 𝛽3𝐶𝑂𝑡ℎ𝑒𝑟 + 𝛽4𝐶𝑆𝑒𝑔𝐷 
and calculated the R2 values for each factor and the overall model, which we report as 
the percent of mappability explained by repetitive elements and segmental duplications. 
4.2.5 Gene set enrichment testing 
We used RNA-Enrich [117] (http://lrpath.ncibi.org) to test for Gene Ontology (GO) 
terms enriched with genes with high or low mappability, which corrected for any effect of 
gene length on average mappability. For GO term enrichment testing of genes with long 
or short locus length, we use LRpath [36] in order to use a continuous measure for gene 
length rather than a method that requires a cut-off to define short and long genes. For 
GO term enrichment testing of the Alu and L1 elements, and segmental duplications, we 
use Broad-Enrich [37]. Broad-Enrich tests for enrichment/depletion of percent coverage 
of repeats across gene loci, while correcting for locus length. This allows us to discover 
gene functions with genes whose loci consist majorly of repeats (enrichment) or rarely 
contain repeats (depletion). Since repeats occurred in almost all genes, using a method 
that reduces the repeat coverage to a binary measure would not have been appropriate. 
In all cases, we corrected p-values for multiple testing using the False Discover Rate 
(FDR) approach. We report results for GO terms with ≤500 genes to avoid overly broad 
terms. 
4.2.6 Clustering 
Gene sets that had significantly high or low mappability (q-value≤0.001) in at 
least two locus regions in at least 1 type of repeat (Alu elements, L1 elements, or 
segmental duplications), were included in the clustering. P-values from gene set 
enrichment testing were log10 transformed and then multiplied by -1 if the gene set was 
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enriched (resulting in a positive number), thereby creating “signed” –log10(p-values). 
Hierarchical clustering was performed using uncentered correlation and average 
linkage. Clustering was performed with gene set enrichment results of GO terms across 
the five locus regions in the following order: exons, introns, TSS extended, ≤5kb from 
TSS, and >5kb upstream from TSS. The order was chosen to show trends using 
different partitions of the genome, from coding (exons) to non-coding (introns) regions, 
overall regions that included the previous and intergenic regions, and then the potential 
regulatory regions surrounding a gene. 
4.2.7 Motif discovery and mappability 
We used MEME (Multiple EM for Motif Elicitation) to perform an unsupervised 
search for transcription factor motifs (with a maximum 21bp width) in the ENCODE 
ChIP-seq experiment for neuron-restrictive silencer factor (NRSF) in cell line K562, with 
6,016 peaks called using the peak finder PePr. MEME output includes a logo of the 
motif as well as a position-specific probability matrix. Sequences for each NRSF peak 
were extracted using the UCSC genome browser. The position-specific probability 
matrix was used as a position weight matrix in the Bioconductor R package, Biostrings, 
to calculate all areas in the human genome where the motif matched ≥80%. Genomic 
coordinates for each instance where the motif was found was extended upstream and 
downstream by 100bp to simulate ChIP-seq peaks. Simulated peaks were overlapped 
with the NRSF peaks to determine potential peaks that were not identified by the peak 
finder. Mappability was calculated for each simulated peak that had a motif and 
compared between simulated peaks that overlapped and did not overlap with the NRSF 
peaks.  
4.3 Results 
4.3.1 Mappability varies by read length and region of gene 
We first describe the mappability of each gene’s overall locus (defined as the 
gene body and its surrounding genomic region) and the mappability of specific regions 
for each gene, such as exons, introns, and upstream regions. We calculated the 
mappability at each base pair for read lengths ranging from 24 to 100mer for human 
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(Figure 4.1a; see methods for details). The overall percent mappability in the human 
genome ranged from 48.6% (for 24mers) up to 93.6% (100mers). As expected, longer 
reads had consistently higher average mappability (Figure 4.1). We then calculated the 
average mappability of the following locus regions for each gene: (1) TSS extended - 
the region between the midpoints of a gene’s TSS and the upstream and downstream 
TSSs of adjacent genes, (2) exons, (3) introns, (4) ≤5kb from TSS- the 5kb region 
upstream and downstream of a TSS, and (5) >5kb upstream from TSS – the region from 
5kb upstream to the midpoint between the gene’s TSS and the neighboring gene TSS 
(Figure 4.1b). The last four locus regions are encompassed in TSS extended. 
In human, using the TSS extended regions, the percent of gene loci having an 
average mappability ≥ 90% for 24, 36, 50, 75, and 100mers was 0.21, 7.41, 24.2, 76.2, 
and 90.1 %, respectively. Although the results for 100mers was very high, still only 2.7% 
of gene loci had 100% unique mappability. For all read lengths, exons were the most 
mappable locus region; this was particularly pronounced for the shorter read lengths 
(Figure 4.2). Focusing on the widely used read length of 50nt, regions >5kb upstream of 
TSS tend to be least mappable, although the distributions of different locus regions 
across all genes are very similar (Figure 4.3a).  
4.3.2 Mappability of repetitive elements and their distribution across genic 
regions 
We next sought to understand how much various factors contribute to the 
mappability of different gene locus regions, and how they are distributed across genes. 
To accomplish this, we examined different locus regions across genes and calculated 
(1) the mappability of different repetitive elements and (2) the proportion of each region 
of each gene covered by these repetitive elements (Figure 4.3b-f). As expected, most 
repetitive elements were not highly mappable, however L1 elements were relatively 
highly mappable with an average of 86% mappabiilty (Figure 4.3d). Segmental 
duplications and Alu elements were least mappable with an average of 41% and 46% 
mappability, respectively. Other repetitive elements were relatively highly mappable with 
an average of 92% mappability. Overall, mappability of Alu and L1 elements were 
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positively correlated with age as measured by percent divergence from consensus 
sequence (Figure 4.4).  
Repetitive elements occurred in almost all TSS extended loci, with Alu elements 
in 98% of genes, L1 elements in 90% of genes, and other repetitive elements in 99% of 
genes. Segmental duplications were associated with only 27% of genes. As expected, 
repetitive elements were least prominent in exons, while segmental duplications were 
most prominent in exons and had a similar distribution of coverage for the other four 
locus regions (introns, ≤5kb from TSS, and >5kb upstream, and TSS extended) (Figure 
4.3). Alu elements on average covered 16-19% of a non-exonic locus region, while L1 
elements covered 6-16% (Figure 4.3b-c). Compared to Alu elements, L1 elements had 
a more significant depletion in coverage in introns and ≤5kb of the TSS. Both Alu 
elements and L1 elements were most prominent in the >5kb upstream from TSS loci, 
which contain distal regulatory regions.  
Overall, repetitive element coverage negatively correlated with mappability. Loci 
with segmental duplications were among those with lower mappability (Figure 4.5). To 
quantitate the contribution of each repeat type to mappability, we created a contribution 
score that measures how much the unmappability (1-mappability) of a locus is due to 
coverage by a repeat type (see methods for further details). Contribution scores of 
repetitive elements and segmental duplications were highly correlated with loci 
mappability (Figure 4.6). We performed linear regression to determine separately and 
altogether how much repetitive elements and segmental duplications contribute to the 
mappability of different locus regions. In order from explaining most to least, the regions 
were ≤5kb of the TSS (95.5%), introns (94.5%), TSS extended (90.3%), >5kb upstream 
from TSS (89.3%), and exons (79.9%) (Figure 4.7). Thus, these repetitive elements 
account for the great majority of the unmappability of regions. The contribution to exon 
mappability may be lowest due to the low coverage of most repetitive elements in these 
regions and because exons may contain many duplicated regions too small to be 
defined as a segmental duplication.  
Also interesting was the range of coverage proportions observed across genes 
both for Alu and L1 elements. For example, although on average only 15% of a gene’s 
promoter region is covered by Alu elements, some genes had as high as >50% Alu 
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element coverage in their promoter while others had <5%. For L1 elements, we 
observed that a certain group of genes had near 0% L1 coverage across their entire 
range, while the rest had a fairly spread out distribution, resulting in a bimodal 
distribution. This led us to wonder whether the types of genes at either end of these 
distributions were random, or whether they tend to belong to certain functions and 
processes. And if so, were they similar or different functions and processes for the 
different contributors to low mappability (Alus, L1s, segmental duplications, etc)? 
4.3.3 Repetitive elements and overall mappability in both genic and 
regulatory regions are associated with gene function and locus 
length 
To assess gene functions that are significantly enriched with or depleted of 
different repetitive element types, we performed gene set enrichment tests using GO 
terms. For comparison, we also performed similar tests for gene functions that have 
significantly higher/lower than average overall mappability, and significantly 
longer/shorter than average locus length. We found gene length to be a potentially 
confounding factor for both mappability and repeat coverage, as the average 
mappability and coverages were correlated with locus length in various ways (Figure 
4.8). Therefore, we used recently-developed tests that empirically adjust for locus length 
and were appropriate for testing mappability and all repeat types. For mappability 
testing, we used a method that automatically adjusts for any relationship with gene 
locus length [117]; for repetitive element testing, we used a method (Broad-Enrich [37]) 
that adjusts for locus length and models the proportion of each gene locus covered by a 
genomic region of interest. Both methods were developed by our group, and allowed us 
to carry out these analyses in an unbiased way.  
For each type of repetitive element we found strong enrichments and depletions, 
with some overlapping GO terms across the different locus regions. For example, we 
found that Alu elements were most strongly depleted in transporter activity, transcription 
factor binding, and brain development; and enriched in immune related functions, and 
olfactory and xenobiotic processes. For L1 elements, we found depletion in early and 
nervous system development functions; and enrichment in olfactory processes, immune 
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related functions, cellular organization, chromatin modifications, and RNA processes. 
Segmental duplications were not as strongly depleted/enriched among gene functions 
as Alu and L1 elements (i.e. gene set enrichment p-values were not as significant). 
Segmental duplications were depleted in early and nervous system development 
functions and processes involved in transcription regulation, and were enriched in 
cellular organization processes, hormone metabolism, cytokine activity, and xenobiotic 
processes. Other top enriched and depleted terms are shown in Table 4.1, and results 
of all GO terms in Supplementary Table 4.1. For locus length, our results are in strong 
agreement with previous reports [54].  
Given the large number of tests performed (5 locus regions x 3 repeat types, plus 
overall mappability and locus length), we wished to visualize the results all together. We 
clustered significance values, using signed –log10(p-values) (negative for depleted 
terms, positive for enriched terms) (Figure 4.9). One of the most notable observations is 
that the overall mappability and locus length results are highly correlated with each 
other and negatively correlated with repetitive element coverages. That is, gene 
functions that have high mappability also tend to have long locus lengths; conversely, 
gene sets with low mappability tend to have shorter locus lengths, albeit with a lesser 
degree of agreement (Figure 4.10). Another notable observation is that while there are 
many gene functions consistently depleted in all three repeat types (Alu elements, L1 
elements, and segmental duplications), and that had high mappability and long locus 
length, there were no gene functions that were consistently enriched in all three.  
Overall, we identified 8 distinct clusters, each with a unique enrichment 
signature. Clusters 1-4 included GO terms that were lowly mappable and had shorter 
locus lengths (using TSS extended). Clusters 1 and 2 were generally depleted in 
segmental duplications but enriched with L1 elements. Cluster 1 was different than 
Cluster 2 in that Cluster 1 was highly enriched with L1 elements in exons and had 
shorter locus lengths. Cluster 1 included terms that were related to RNA (28.6%) - such 
as RNA catabolic process, ribosome, and mRNA transport, mitochondria - such as 
mitochondrial matrix and mitochondrial respiratory chain, and terms related to 
transcription and translation. Cluster 2 included terms that were related to cellular 
organization and division such as microtubule, spindle assembly and kinetochore, 
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protein modifications such as protein targeting and histone modification, and chromatin 
such as centrosome and chromosomal part. Cluster 3 differed from Clusters 1 and 2 in 
that it was enriched with segmental duplications and depleted of L1 elements except in 
TSS extended, suggesting that L1 elements were enriched in regions downstream of 
the TSS. Cluster 3 was dominated by terms related to immune response–response to 
bacterium and innate immune response, cell signaling such as cytokine activity and 
steroid metabolic process, and protein secretion. Cluster 4 was unlike cluster 3 in that it 
exhibited very strong enrichment of Alu elements. It included terms related to 
immunoglobulin binding, as well as GO terms like mismatch repair, olfactory receptor 
activity, and heme binding. GO terms in clusters 1-4 where those whose genes allowed 
the most repetitive elements of various types in their surrounding locus regions, 
suggesting they may be under strong positive selection.  
The other half of the heatmap, Clusters 5-8, included GO terms that were highly 
mappable and had longer locus lengths. Cluster 5, which was depleted in Alu elements 
and segmental duplications, and mixed for L1s (enriched with L1 elements only in the 
region ≥5kb upstream from TSS) was dominated by terms related to kinase activity, 
transcription factor binding, actin, and regulation of GTPase. Cluster 6 was strongly 
depleted of L1 elements and somewhat enriched with segmental duplications; it 
included many terms related to ion channel activity and ion transportation, and some 
developmental terms such as head development, vasculature development, and kidney 
development. Cluster 7, the largest cluster, was depleted in Alu elements, L1 elements, 
and segmental duplications. The majority of this cluster is terms related to development, 
as 72% of the GO terms in this cluster included the word “development,” “formation,” 
“differentiation,” or the suffix “-genesis.” The development terms were related to organ 
formation, tissue development, embryo development and nervous system development, 
including terms such as brain development, axon, dendrite, and synapse. Non-
developmental terms included transcription factor complex and transcription regulatory 
region sequence-specific DNA binding, processes where mutations or repetitive 
element insertion could cause widely detrimental trans-regulation effects. Cluster 8 was 
the smallest cluster, distinct in that it was enriched only with Alu elements. This cluster 
included specific terms such as cranial nerve development, regulation of kidney 
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development, and developmental pigmentation. The full list of GO terms associated with 
each cluster is shown in Supplementary Table 4.2. 
4.3.4 Comparison of mouse and human mappability and locus length 
To determine the extent to which our above findings are limited to human, versus 
generalize to other mammals, we performed a simplified analysis in mouse testing for 
gene functions enriched with high/low mappability and long/short locus length. We 
found that GO terms with high mappability in human were also generally highly 
mappable in mouse (Figure 4.11a, r =0.35) such as terms related to nervous system 
development, early development, and transcription factor binding. Over 500 GO terms 
had significantly high mappability in both species using the TSS extended regions; 
these included terms related to nervous system development like axon guidance, 
regulation of neurogenesis, and synaptic membrane, as well as pattern specification 
process, regionalization, and sequence-specific DNA binding RNA polymerase II 
transcription factor activity. There was less agreement with lowly mappable terms, 
however there were still seventeen terms overlapping between the two species, 
including olfactory receptor activity and defense response to bacterium (Figure 4.11a). 
This divergence for lowly mappable gene functions suggests the possibility that the 
different repetitive element types in mouse compared to human have been adapted to 
help regulate different types of processes, and/or that different types of genes are more 
likely to have a segmental duplication. Overall, there was higher concordance between 
human and mouse for GO terms enriched with long genes or short genes than there 
was for mappability (Figure 4.11, r=0.35 for mappability, and r=0.59 for locus length). 
There were 445 GO terms that were both highly mappable and had long locus lengths 
in both human and mouse (q ≤0.05 and ≤500 genes); of those, 187 (42%) included the 
word “development”, “formation, “differentiation” or the suffix “-genesis.” The top ranked 
GO terms with high mappability and long locus length in both species were regulation of 
neuron differentiation and morphogenesis of an epithelium. Mouse enrichment results 
are provided in Supplementary Table 4.3.  
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4.3.5 Effect of mappability on ChIP-seq peak detection 
Finally, we asked how variations in mappability might affect the ability of ChIP-
seq to detect true DNA protein binding. Successful peak detection (detection of protein-
DNA binding sites) requires the ability to uniquely align sequencing reads to the binding 
region. Binding sites in regulatory regions with lower mappability are less likely to be 
detected, because fewer reads can be mapped to those regions. To investigate this, we 
calculated the mappability of the region surrounding a DNA binding protein motif and 
asked if motifs under ChIP-seq peaks for that DNA binding protein had higher 
mappability than motifs not in a peak. Specifically, we used Motif Em for Motif Elicitation 
(MEME[118]) to scan for DNA binding motifs in 6,016 peaks (called by PePr [119]) from 
the ENCODE ChIP-seq experiment for neuron-restrictive silencer factor (NRSF) in cell 
line K562, an immortalised myelogenous leukemia cell line. As expected, the most 
prominent motif was for NRSF (Figure 4.12a). Using the resulting position weight matrix 
(PWM), we identified 17,021 predicted NRSF motif sites in the genome (hg19). Of these 
computationally predicted motif sites, 2,607 (15.3%) occurred in a ChIP-seq peak; these 
motif sites tended to occur near the center of the peaks (Figure 4.12b). We compared 
the mappability of motifs in ChIP-seq peaks to those outside of peaks, calculating the 
mappability of the regions 100bp up- and down-stream of each motif site. Motif regions 
in ChIP-seq peaks had significantly greater mappability than motif regions not in a peak 
(p =8.65x10-6) (Figure 4.12c). A likely explanation is that many of the NRSF bound 
regions with lower mappability were not detected by the peak calling algorithm. If true, 
given the results of the previous sections, undetected binding sites may be in the loci of 
genes with low mappability; and thus the detected binding sites may be enriched for 
subsets of genes (and GO terms) with high mappability. 
4.4 Discussion 
The mappability of genomic loci is directly related to sequence uniqueness. 
Factors that affect the mappability of genomic regions include read length and presence 
of repetitive elements such as transposons and segmental duplications. Our partitioning 
of the genome into five different locus regions: (1) TSS extended, (2) exons, (3) introns, 
(4) ≤5kb from TSS, and (5) >5kb upstream from TSS showed different patterns of 
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mappability and coverage of repetitive elements and segmental duplications. Repetitive 
elements and segmental duplications explained >90% of unmappable sites in all locus 
regions except exons. As expected, exons were generally most highly mappable and 
had the lowest amount of repetitive elements and segmental duplications. Any 
unmappability in exons not explained by repetitive elements and segmental duplications 
may be due to other factors, such as duplications not long enough to be categorized as 
segmental duplications, but are replicated to code for the same protein domain in 
various proteins. One example is tandemly duplicated exons, estimated to occur in 
about 10% of annotated genes in Homo sapiens, that are present in expressed 
sequence tags and cDNAs, and therefore are likely functional [120].  
Loci with Alu and L1 elements and segmental duplications depleted or enriched 
with gene functions. Across the different repetitive elements and segmental duplications 
we examined, we showed that certain gene functions exhibit specific repeat enrichment 
signatures and many of these coincide with the enrichment signatures of overall 
mappability and locus length. Furthermore, results for repeat elements varied across 
different locus regions. We observed depletion, but never strong enrichment, of all three 
repeat types across all locus regions, implying that certain regions tend to tolerate a 
specific type of repeat, but do not tolerate repetitive elements in general. 
The strong associations of Alu elements, L1 elements, and segmental 
duplications with gene function show that incorporation and proliferation of repeats is 
not random, and suggest locus-specific tolerance. Our results also suggest that the 
selection for one type of repeat over another may be because that repeat type is 
beneficial to regulation of genes involved in that function, and perhaps that repeat type 
has even been adapted for use by the genes, a process called exaptation. For example, 
cluster 3 of the heatmap (Figure 4.9) showed a signature highly enriched for Alu 
elements in genes involved with immune response. It has been previously shown that 
an Alu element had been exapted as a highly conserved binding site for the CAMP 
gene, which is regulated in the vitamin D pathway, a pathway involved in innate immune 
response in humans and primates [121].  
The top enrichment results for segmental duplications were less significant than 
for Alu and L1 elements. Segmental duplications occur at a larger scale than 
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transposons, often resulting in large blocks of duplications, and inter- and intra-
chromosomal rearrangements; therefore, survival of segmental duplications may be 
less dependent on gene regulation mechanisms. Rather genes in gene functions 
enriched with segmental duplications may have one or a combination of favorable 
features: (1) tolerant of having duplications, (2) located in regions of chromosomes 
(pericentromeric, subtelomeric, and “duplication cores” [122] ) that are more likely to be 
duplicated and re-arranged , and/or (3) have simpler regulation not requiring many 
unique sequences. For the gene functions in cluster 3 (Figure 4.9) that are enriched 
with segmental duplications and Alu elements, it is possible that these are the result of a 
positive relationship between segmental duplications and Alu elements. It has been 
shown that a significant amount of pericentromeric and interstitial (occurring in 
euchromatin) segmental duplications are enriched with AluY and AluS, younger 
subfamilies of Alu elements, at the boundaries of segmental duplication events [123, 
124]. 
We consistently found developmental genes, especially those involved in 
nervous system development and early development, to be highly mappable, have 
longer locus length, and to be strongly depleted of Alu and L1 elements, and segmental 
duplications in multiple locus regions. While this is expected for coding regions like 
exons, depletion in surrounding intergenic regions suggest these functions require more 
unique sets of sequences and potentially preserved distances between them,to 
maintain proper regulation from promoter and enhancer regions. Genes in these 
processes tend to be consistent across everything tested, having both longer and more 
highly mappable intergenic space around them. These findings agree with and expand 
on those of Simons, et al. [21], i.e. that transposon-free regions are highly enriched in 
developmental genes. Interestingly, these genes may also be resistant to acquiring 
mutations. For example, ultra-conserved elements have been found to be enriched in 
“gene deserts” that are 10-100 kilobases (kb) away from known genes, where the 
closest flanking genes are associated with early development functions [125, 126]. Also 
consistent with the idea that developmental genes require complex regulation and 
therefore more sequence uniqueness, Lawson and Zhang [127] found that the 5’-UTRs 
of tissue-specific genes, which often require complex regulatory control, have 
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significantly fewer simple sequence repeats than the 5’-UTRs of housekeeping genes. 
Tissue-specific regulation requires the cooperation of multiple transcription factors, and 
thus multiple binding locations [128], and genes with complex expression patterns often 
require long-range cis-regulatory elements. This was first revealed by the fact that 
intergenic chromosomal breaks in disease disrupted these genes [129].  
The relationships we have described among transposons, segmental 
duplications, mappability, and gene locus length with gene function, suggest that 
mappability may need to be taken into account when looking at the biological relevance 
of genomic regions from genome-wide sequencing results. In particular, genes involved 
in biological functions tending to have high mappability will be more likely identified than 
genes involved in functions tending to have low mappability, simply due to higher 
sequence coverage. Our example of how mappability affects ChIP-seq peak detection 
with the NRSF dataset shows that even though many of our computationally predicted 
binding sites were likely false positives, we were still able to detect a significant shift 
towards higher mappability in the sites covered by a detected peak. These results are in 
agreement with those of Rozowsky, et al. [88] who found that mappability had a 
significant effect on modifying the overall ChIP-seq signal.  
Our analyses were made possible by gene set enrichment tests [37, 117] that are 
able to account for confounding factors and to measure the proportion of loci covered by 
a repeat. It is well known that gene locus length can bias gene set enrichment tests [54], 
and it should therefore be accounted for. A previous study by Tsirigos, et al [130], who 
used a permutation-based approach to find gene functions enriched with Alu elements 
in the human genome did not take into account gene locus length. We compared our 
results to theirs and found little agreement. In the case of highly occurring genomic 
features, such as repetitive elements and segmental duplications, gene set enrichment 
tests that reduce the genomic features to a binary value or even the number of features, 
would not be as informative since, or almost all genes, would have that genomic feature 
and they can be various lengths. The method we used, Broad-Enrich [37], uses 
percentage of loci covered by the repeat type for gene set enrichment testing, and 
therefore is well-suited for Alu and L1 elements, and segmental duplications. 
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There are multiple limitations of our study and/or future directions for further 
analysis. Mappability may play an even larger role in bisulfite sequencing studies, where 
unmethylated cytosines are converted to uracil (and read as thymine on sequencers). In 
these studies, the genome is essentially reduced to a three letter alphabet, significantly 
reducing the unique information content of short read sequences. Although we identified 
many significant associations, our study was limited by our method of using nearest 
genes for defining gene regulatory regions. Future studies may take into account 
insulators (e.g., CTCF sites) and identified DNA loops between enhancer and proximal 
promoter regions, which could refine enrichment results. In our study, we focused on 
read lengths of 50bp. Although sequencers are now capable of longer reads, these 
short read results remain relevant due to the large number of publicly-available 
sequencing experiments available and still being extensively used that were performed 
with shorter reads. For example, nearly all of the ENCODE ChIP-seq data were 
performed with 35-40nt read length (ENCODE TFBS metadata, column Z). Finally, 
other classes and subclasses of LINEs and SINEs, besides Alu and L1 elements, may 
be associated with different gene functions. Liang, et al. [131] found that tandem 
repetitive elements, unlike transposable elements, were more highly enriched in genes 
involved with development and regulation functions, especially in 5’ UTR regions. 
However, their analysis did not take into account gene locus length, and only looked at 
the presence (while we look at the proportion) of a repetitive element in 5’-, 3’-UTR, and 
set regions upstream and downstream of the transcription start/end sites. Our approach 
in this study can further be applied to other repeat types as well.  Also of particular 
interest would be an analysis of subfamilies of Alu and L1 elements, as these 
subfamilies are of different ages and sequence similarity. Segmental duplications that 
are >10kb and >95% identity are more prone to duplication-mediated rearrangements 
and non-allelic homologous recombination [103, 132, 133]. Paralogous segmental 
duplications or segmental duplications of different lengths and identity may be 
associated with distinct gene functions, not captured in this analysis. Also of interest 
could be a comparison of pericentromeric, subtelomeric, and interstitial segmental 
duplications. There is much more to discover, but here we have described and applied 
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the most comprehensive study of depletion and enrichment of highly occurring repetitive 
elements in gene functions across different gene locus regions in the human genome.  
4.5 Figures and Tables 
 
 
 
Figure 4.1. Illustration of locus definitions and example of mappability calculation.  
(a) An example our mappabiilty calculation using a Kmer read. Original values from UCSC CRG mappability tracks 
are 1/number of locations to which the read aligns. We convert UCSC mappability to 1 if the read sequence is unique, 
otherwise it is assigned a value of 0. Each base pair in the genome is given a base pair mappabiilty (Bi), which is the 
average number of uniquely mappable reads that span over base pair i. Mappability of a gene’s loci is the average of 
all Bi in the loci. (b) We created five different locus definitions: TSS extended - the region between the midpoints of a 
gene’s TSS and the upstream and downstream TSSs of adjacent genes, exons – the exons of a transcript of a gene, 
introns – the regions between two exons of a transcript of a gene, ≤5kb from TSS - the 5kb region surrounding a 
TSS, and >5kb upstream from TSS- the region >5kb upstream of a TSS.  
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Figure 4.2. Density curves of mappability of TSS extended loci show increased mappability as read length 
increases. 
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Figure 4.3. Distribution of mappability and repetitive elements across different loci. (a) Distribution of average 
mappability (50mer) across genes for different locus regions and (b) different repetitive elements: Alu, L1, and other 
repetitive elements. (c-f) Density curves across genes showing proportion of loci consisting of (c) Alu elements, (d) L1 
elements, (e) other repetitive elements, and (f) segmental duplications. Panels b-f have inset plots excluding the most 
dominating density curve. 
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Figure 4.4. Mappability of a Alu and L1 elements are positively correlated with age as measured by percent 
divergence from consensus sequence. Spearman’s correlation is 0.72 for Alu elements and mappability, and 0.54 
for L1 elements and mappability. 
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Figure 4.5. Scatterplots of mappability using 50mer reads and proportion of loci that are Alu elements, L1 
elements, and other repetitive elements show generally that gene loci that contain larger proportion of a repetitive 
element have lower mappability and vice versa. Alu elements affect mappability more so than other repetitive 
elements in the all the different loci. Each point (i.e. gene) is colored blue if that gene locus has no respective 
repetitive element and no segmental duplications. Black points are gene loci with the respective repetitive element 
but do not have any segmental duplications. Blue points are gene loci with no respective repetitive element and no 
segmental duplications. Green points are gene loci that have both the respective repetitive element and at least one 
segmental duplication. Pink points are gene locus that have no respective repetitive element but do have at least one 
segmental duplication. Having at least one segmental duplication also decreases mappability. Gene loci that have at 
least one segmental duplication can have much lower mappability that those that do not, even when there are no 
repetitive elements, or are repetitive elements such as L1 elements and other repetitive elements that tend to be 
more highly mappable than Alu elements. 
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Figure 4.6. Contribution scores of repetitive elements and segmental duplications are correlated with 
mappability. 
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Figure 4.7. Individual contribution of repetitive elements and segmental duplications to mappability.  
In order from explaining mappabiilty most to least, the regions were ≤5kb of the TSS (95.5%), introns (94.5%), TSS 
extended (90.3%), >5kb upstream from TSS (89.3%), and exons (79.9%). 
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Figure 4.8. Relationship of (a) mappability, (b) Alu elements, (c) L1 elements, and (d) segmental duplications 
with gene length. (b-d) are output plots from Broad-Enrich, genes are grouped into bins of 25 genes ordered by 
locus length. Locus length here is calculated from TSS extended regions. 
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Figure 4.9. Heatmap showing signed –log10(p-values) (negative for depleted terms, positive for enriched 
terms) of GO gene set enrichment results. The first five columns are enrichment results for the different loci using 
proportion of Alu elements, the second set of five columns are enrichment results for the different loci using 
proportion of L1 elements, the third set of five columns are enrichment results for the different loci using proportion of 
segmental duplications, and the last two columns are enrichment results for highly/lowly mappable GO terms and 
short/long locus lengths using the TSS extended loci. We identified 8 distinct clusters of GO terms that show similar 
enrichment patterns. GO terms included were limited to those that had less than 500 genes and FDR≤0.001 in at 
least two locus definitions in at least one type of repetitive element or segmental duplications, which resulted in 510 
gene sets. 
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Figure 4.10. Mappability and locus length in human have similarly enriched gene sets. Each point represents a 
GO term. The axes are signed –log10(p-value), i.e. +log10(p-value) if long locus length/high mappability, or -log10(p-
value) if short locus length/low mappability using TSS extended locus regions and 50mer mappability. Purple 
indicates terms that have long locus length/high mappability. Green indicates terms with short locus length/low 
mappability. Turquoise indicates terms with long locus length/high mappability. Gold indicates terms with short locus 
length/low mappability. Pink indicates terms that have only significantly short locus length. Dark red indicates terms 
that have only significantly long locus length. Bright red indicates terms that have only significantly low mappability. 
Dark blue indicates terms that have only significantly high mappability. The remaining terms are indicated in black. 
Reported GO terms are limited to those with ≤500 genes 
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 Figure 4.11. Human and mouse have similarly enriched gene sets for (a) high and low mappability and (b) 
long and short locus lengths. Each point represents a GO term. The axes are signed –log10(p-value), i.e. +log10(p-
value) if highly mappable/long locus length, or -log10(p-value) if lowly mappable/short locus length in mouse or human 
using 50mer mappability from TSS extended locus regions. Purple indicates terms that have high mappability/long 
locus length in both human and mouse. Green indicates terms with low mappability/short locus length in human and 
high mappability/long locus length in mouse. Turquoise indicates terms with high mappability/long locus length in 
human and low mappability/short locus lengths in mouse. Gold indicates terms with low mappability/short locus 
length in both human and mouse. Pink indicates terms that are only significantly lowly mappable/short locus length in 
human. Dark red indicates terms that are only significantly highly mappable/long locus length in human. Bright red 
indicates terms that are only significantly lowly mappable/short locus length in mouse. Dark blue indicates terms that 
are only significantly highly mappable/long locus length in mouse. The remaining terms are indicated in black. 
Reported GO terms are limited to those with ≤500 genes. 
  
Low mappability High mappability Short locus length Long locus length 
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Figure 4.12. NRSF ChIP-seq results. (a) Motif logo identified by MEME using peaks called by PePr; (b) histogram 
showing that motifs had a strong tendency to occur in the middle of a peak; (c) histograms showing that the predicted 
NRSF binding sites in peaks (blue) tend to have higher mappability than the computationally predicted NRSF binding 
sites not overlapping a peak (orange) (p =8.65x10
-6
). 
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Table 4.1. Select significantly enriched/depleted GO terms. Top 5 non-related terms for each repeat type and 
locus regions, limited to GO terms with ≤500 genes. The full list is in Supplementary Table 4.1. 
a) Top GO terms significantly enriched with Alu elements 
GO term Branch Locus Regions 
(q-value ≤0.05) 
Average 
Mappability 
Locus Length  
%tile 
dichotomous subdivision of an epithelial 
terminal unit 
BP intron, exon, ≤5kb, >5kb 
up. 
0.62 88 
enteric nervous system development BP intron, exon, ≤5kb, >5kb 
up. 
0.66 61 
glucuronosyltransferase activity MF All 0.76 43 
heme binding MF TSS ext., intron, exon, 
>5kb up. 
0.77 16 
IgG binding MF All 0.25 1.7 
immunoglobulin binding MF All 0.51 2.3 
keratin filament CC intron, exon, >5kb up. 0.81 0.019 
MHC class I protein complex CC All 0.7 0.42 
monooxygenase activity MF TSS ext., intron, exon, 
>5kb up. 
0.76 22 
olfactory receptor activity MF intron, exon, ≤5kb, >5kb 
up. 
0.73 26 
oxidoreductase activity, acting on paired 
donors,… 
MF TSS ext., intron, exon, 
>5kb up. 
0.69 3.9 
positive regulation of kidney development BP intron, exon, ≤5kb, >5kb 
up. 
0.64 92 
response to xenobiotic stimulus BP All 0.76 16 
b) Top GO terms significantly depleted with Alu elements 
GO term Branch Locus Regions 
(q-value ≤0.05) 
Average 
Mappability 
Locus Length  
%tile 
brain development BP intron, exon, >5kb up. 0.87 88 
cell division BP exon 0.83 41 
inorganic cation transmembrane transporter 
activity 
MF intron, exon, >5kb up. 0.85 64 
metal ion transport BP intron 0.86 59 
protein binding transcription factor activity MF TSS ext., exon, >5kb up. 0.85 63 
regulation of cell development BP intron, exon, >5kb up. 0.87 88 
regulation of nervous system development BP intron, exon, >5kb up. 0.87 90 
sensory organ development BP intron 0.86 78 
synapse CC TSS ext., intron, exon, 
>5kb up. 
0.86 91 
c) Top GO terms significantly enriched with L1 elements 
GO term Branch Locus Regions 
(q-value ≤0.05) 
Average 
Mappability 
Locus Length  
%tile 
chromatin modification BP intron, ≤5kb, >5kb up. 0.83 45 
chromosomal part CC intron, ≤5kb, >5kb up. 0.82 32 
keratin filament CC TSS ext. 0.81 0.019 
keratinization BP TSS ext. 0.84 1.9 
mitochondrial membrane CC intron, exon, ≤5kb, >5kb 
up. 
0.81 15 
mitochondrial membrane part CC intron, exon, 5kb 0.79 11 
monooxygenase activity MF TSS ext. 0.76 22 
mRNA processing BP intron, ≤5kb, >5kb up. 0.81 22 
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olfactory receptor activity MF TSS ext. 0.73 26 
protein folding BP intron, 5kb 0.81 31 
ribosome CC intron, exon, 5kb 0.8 3.3 
RNA catabolic process BP intron, exon, ≤5kb, >5kb 
up. 
0.8 5.2 
RNA splicing BP intron, ≤5kb, >5kb up. 0.81 24 
SRP-dependent cotranslational protein 
targeting to membrane 
BP intron, exon, 5kb 0.79 2.5 
structural constituent of ribosome MF intron, exon, 5kb 0.8 3.1 
transcription cofactor activity MF >5kb up. 0.85 63 
transcription factor binding MF >5kb up. 0.83 65 
translational termination BP intron, exon, 5kb 0.77 1.7 
unfolded protein binding MF intron, 5kb 0.81 7.6 
viral genome expression BP intron, exon, ≤5kb, >5kb 
up. 
0.8 3 
viral reproduction BP intron, exon, ≤5kb, >5kb 
up. 
0.81 9.1 
xenobiotic metabolic process BP TSS ext. 0.76 16 
d) Top GO terms significantly depleted with L1 elements 
GO term Branch Locus Regions 
(q-value ≤0.05) 
Average 
Mappability 
Locus Length  
%tile 
actin filament-based process BP exon, TSS ext. 0.84 64 
axon CC intron, exon, ≤5kb, TSS 
ext. 
0.86 95 
axonogenesis BP intron, exon, ≤5kb, TSS 
ext. 
0.86 93 
behavior BP intron, exon, ≤5kb, >5kb 
up. 
0.86 82 
brain development BP intron, exon, ≤5kb, TSS 
ext. 
0.87 88 
dendrite CC intron, exon, ≤5kb, TSS 
ext. 
0.86 94 
embryonic morphogenesis BP intron, exon, ≤5kb, TSS 
ext. 
0.86 78 
extracellular matrix CC intron, exon, ≤5kb, >5kb 
up. 
0.85 69 
intermediate filament CC intron, exon, ≤5kb, >5kb 
up. 
0.84 1.8 
monooxygenase activity MF intron, ≤5kb, >5kb up. 0.76 22 
olfactory receptor activity MF intron, ≤5kb, >5kb up. 0.73 26 
pattern specification process BP intron, exon, ≤5kb, TSS 
ext. 
0.86 75 
phospholipid binding MF exon, TSS ext. 0.83 69 
regulation of cell development BP intron, exon, ≤5kb, TSS 
ext. 
0.87 88 
regulation of nervous system development BP intron, exon, ≤5kb, TSS 
ext. 
0.87 90 
regulation of system process BP All 0.87 76 
sensory perception BP intron, ≤5kb, >5kb up. 0.85 57 
skeletal system development BP All 0.86 77 
synapse CC intron, exon, ≤5kb, TSS 
ext. 
0.86 91 
tissue morphogenesis BP intron, exon, ≤5kb, TSS 0.86 81 
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ext. 
tube development BP intron, exon, ≤5kb, TSS 
ext. 
0.85 87 
vasculature development BP intron, exon, ≤5kb, TSS 
ext. 
0.86 79 
xenobiotic metabolic process BP intron, ≤5kb, >5kb up. 0.76 16 
e) Top GO terms significantly enriched with segmental duplications 
GO term Branch Locus Regions 
(q-value ≤0.05) 
Average 
Mappability 
Locus Length  
%tile 
branched-chain amino acid catabolic process BP exon 0.81 28 
channel activity MF intron, TSS ext. 0.85 73 
CoA hydrolase activity MF exon, 5kb 0.75 3.9 
cytokine activity MF intron, TSS ext. 0.84 21 
cytokine receptor activity MF intron, ≤5kb, TSS ext. 0.82 28 
defense response to bacterium BP intron, ≤5kb, TSS ext. 0.76 14 
high-density lipoprotein particle CC exon 0.81 0.19 
hormone metabolic process BP >5kb up., TSS ext. 0.82 41 
immune effector process BP intron, TSS ext. 0.82 28 
inflammatory response BP intron, ≤5kb, TSS ext. 0.82 34 
innate immune response BP intron, ≤5kb, TSS ext. 0.81 21 
ion channel activity MF intron, TSS ext. 0.86 76 
lipid catabolic process BP intron, ≤5kb, >5kb up., 
TSS ext. 
0.83 28 
mitochondrial matrix CC 5kb, TSS ext. 0.81 13 
oxidoreductase activity, acting on CH-OH group 
of donors 
MF 5kb, >5kb up. 0.81 22 
regulation of defense response to virus by host BP exon 0.77 15 
response to bacterium BP intron, TSS ext. 0.81 35 
response to xenobiotic stimulus BP intron, ≤5kb, >5kb up., 
TSS ext. 
0.76 16 
small molecule catabolic process BP 5kb, TSS ext. 0.82 30 
steroid metabolic process BP intron, ≤5kb, >5kb up., 
TSS ext. 
0.82 27 
transferase activity, transferring hexosyl groups MF intron, ≤5kb, >5kb up., 
TSS ext. 
0.82 75 
transferase activity, transferring one-carbon 
groups 
MF exon 0.8 16 
xenobiotic metabolic process BP intron, ≤5kb, >5kb up., 
TSS ext. 
0.76 16 
f) Top GO terms significantly depleted with segmental duplications 
GO term Branch Locus Regions 
(q-value ≤0.05) 
Average 
Mappability 
Locus Length  
%tile 
actin cytoskeleton CC intron, exon, TSS ext. 0.84 41 
actin filament-based process BP exon, TSS ext. 0.84 64 
axon guidance BP All 0.85 92 
axonogenesis BP intron, exon, ≤5kb, TSS 
ext. 
0.86 93 
cell-cell adhesion BP exon, 5kb 0.85 96 
chordate embryonic development BP intron, ≤5kb, >5kb up., 
TSS ext. 
0.86 72 
chromatin binding MF intron, ≤5kb, TSS ext. 0.84 67 
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chromatin organization BP intron, ≤5kb, TSS ext. 0.83 37 
embryonic morphogenesis BP intron, ≤5kb, TSS ext. 0.86 78 
homophilic cell adhesion BP exon, 5kb 0.86 99 
Microtubule CC intron, exon, TSS ext. 0.82 44 
mRNA processing BP intron, TSS ext. 0.81 22 
muscle structure development BP intron, ≤5kb, TSS ext. 0.87 79 
negative regulation of transcription from RNA 
polymerase II promoter 
BP intron, ≤5kb, >5kb up., 
TSS ext. 
0.85 75 
pattern specification process BP intron, ≤5kb, >5kb up., 
TSS ext. 
0.86 75 
posttranscriptional regulation of gene 
expression 
BP intron, 5kb 0.83 31 
regionalization BP intron, ≤5kb, TSS ext. 0.88 72 
regulatory region DNA binding MF intron, ≤5kb, TSS ext. 0.86 73 
tissue morphogenesis BP intron, ≤5kb, TSS ext. 0.86 81 
tubulin binding MF intron, >5kb up., TSS ext. 0.82 44 
 
Supplementary Table 4.1. Enriched and depleted GO terms for Alu and L1 elements, and segmental 
duplications for all locus regions (extended version of Table 4.1). 
Supplementary Table 4.2. Full list of GO terms associated with clusters from Figure 4.9. 
Supplementary Table 4.3. GO term enrichment results for mappability and locus length, comparing mouse 
and human.  
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 Conclusions & Future Directions Chapter 5
5.1 Conclusions 
In this dissertation, I contributed to the tools available for functional interpretation 
of high-throughput sequencing data such as ChIP-seq and RNA-seq data, as well as 
characterizing the main contributing factors to read mappability at the pathway level. 
Overall, the research I present has and will further our understanding of how gene 
length, read count, and read mappability can affect statistical tests for HTS data.. 
 In Chapter 2, we introduced ChIP-Enrich, a gene set enrichment test for ChIP-
seq data that adjusts for gene locus length in peak-to-gene assignments. ChIP-Enrich 
consists of two main parts: (1) locus definitions that allow peak-to-gene assignments for 
studying various genic and regulatory regions, and (2) a gene set enrichment test that 
empirically adjusts for the observed relationship between locus length and probability of 
having at least one peak in the gene loci. We showed through permutation testing that 
unlike other existing GSE tests, Fisher’s exact test and the binomial test, ChIP-Enrich 
maintains an acceptable type I error rate even when there exists a relationship between 
locus length and probability of having at least one peak. We applied ChIP-Enrich to 63 
ENCODE datasets that included transcription factors and histone modifications, and 
were generated using different peak callers. The datasets varied widely by binding 
patterns as well as number of peaks. We showed that ChIP-Enrich was able to account 
for all types of relationships between locus length and peak presence. FET was only 
appropriate for data sets where there was no relationship between locus length and 
peak presence. The other test we compared ChIP-Enrich to was the binomial test, 
which assumes number of peaks is proportional to locus length. However, for datasets 
with high number of peaks, which were the same datasets that often had peaks 
proportional to locus length, the binomial test underestimates variance because of over-
dispersion of peaks among genes. This resulted in incorrect p-values and inflated type I 
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error. In addition, we showed that limiting peaks to a restrictive locus definition, ≤1kb 
from TSS, compared to an all-inclusive locus definition, nearest TSS, resulted in 
different discovered biology. We further examined the effect of the locus definition by 
applying ChIP-Enrich to a ChIP-seq dataset of glucocorticoid receptor activity in A549 
cells treated with Dex, and showed that using two locus definitions, ≤1kb from TSS and 
nearest TSS, elucidated different regulatory activity of GR in proximal and distal 
regulatory regions.  
 In Chapter 3, we introduced RNA-Enrich, a gene set enrichment test for RNA-seq 
data that corrects for any selection bias due to varying read counts. To correct for this 
relationship, weights for genes were created using a spline fitted to average gene read 
count and significance values like differential gene expression p-values. Therefore if 
genes that were more likely to have higher read counts, like highly expressed, long 
genes, also had more significant p-values, then those genes were weighed less and 
were less influential in enrichment of a gene set. Unlike other GSE tests for RNA-seq 
data such as DAVID (which uses a modified Fisher’s exact test) and GOseq (which can 
also adjust for read count), RNA-Enrich does not require a cut-off to define differentially 
expressed genes. And unlike permutation-based tests like GSEA, GSAASeqSP, and 
SeqGSEA, RNA-Erinch does not require large sample sizes for power and accuracy, or 
a long run-time. RNA-Enrich also had substantially improved type I error compared to 
DAVID and GOseq, and maintained similar performance when we used p-values from 
DEseq instead of edgeR or a correct log fold change. 
 With ChIP-Enrich and RNA-Enrich, we showed that gene length and read count, 
respectively, can affect functional interpretation of ChIP-seq and RNA-seq data. 
However our GSE tests are not limited to these two types of HTS data. Here are some 
examples: ChIP-Enrich may also be applied to GWAS data, especially if genes with 
longer locus length are more likely to have significant SNP variants. In Chapter 4, we 
used RNA-Enrich to perform GSE testing of mappability, in which case we used 
mappability values as the significance values and locus length instead of read count. 
Bisulfite sequencing data may also be a good candidate for RNA-Enrich. Some bisulfite 
sequencing platforms arebias toward CpG islands, thus genes with more CpGs may be 
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more likely to be identified as differentially methylated. Genes with more intergenic 
distance may also be more likely to contain CpGs. 
 We first introduced the concept of mappability in Chapter 2 as an option for ChIP-
Enrich. However we did not further expand on how much effect mappability has on gene 
set enrichment testing after accounting for gene length. We showed in Chapter 4 that 
certain gene functions do tend to have higher or lower mappability, and therefore 
mappability should be considered in GSE tests. We also showed that mappability of 
potential DNA protein binding sites can affect which peaks would be detected in ChIP-
seq. Thus we explored how certain gene functions had more or less mappable genes, 
and how that concurred with gene locus length. Our analysis of mappability and gene 
length showed that gene sets that tend to have shorter genes were also lowly 
mappable, while gene sets that tend to have longer genes were also highly mappable. 
We also found similar highly/lowly mappable and longer/shorter locus length gene sets 
in mouse, suggesting some conservation of gene functions across different species. 
We suggested that in addition to co-varying with gene length, mappability can 
also be indicative of the complexity of gene regulation. Genes that need more complex 
regulation would need more unique surrounding sequence and intergenic distance. We 
expanded our analyses of mappability and gene length to include repetitive genomic 
features like transposons and segmental duplications. We showed that mappability is 
strongly affected by transposons and segmental duplications, which are both lowly 
mappable. We further analyzed the most prominent LINE elements, L1 elements, and 
the most prominent SINE elements, Alu elements, in the human genome, as well as 
segmental duplications. We discovered distinct enrichment and depletion signatures of 
Alu and L1 elements, segmental duplications, mappability and gene length exhibited by 
certain gene functions. For example, genes involved with development were strongly 
depleted of repeat elements, were highly mappable, and had longer genes - all of which 
suggest evolutionary pressure to maintain unique sequence and long intergenic 
distances for complex regulation of developmental genes. Gene sets enriched with Alu 
elements, L1 elements, and/or segmental duplications suggest evolutionary selection 
for the repeat element, and perhaps adaptation of the element for the gene’s own 
benefit. Overall, we showed that mappability is indicative of genomic architect and 
116 
 
complexity of gene regulation. We found certain gene functions are more highly or lowly 
mappable, and therefore can bias GSE of ChIP-seq data. Fortunately our GSE test, 
ChIP-Enrich has the option to correct for mappability and therefore is robust to this 
effect.  
Throughout this dissertation, we demonstrated that considering characteristics of 
the human genome is essential to improving functional interpretation of HTS data. The 
GSE tests we have developed have enabled us to perform functional interpretation of 
HTS data, repetitive elements and segmental duplications, and mappability for the first 
time taking into account locus length. 
5.2 Future Directions 
5.2.1 Chapter 2 
 In developing ChIP-Enrich, we generated various locus definitions for assigning 
peaks to genes, each resulting in different locus lengths. The regulatory regions we 
assigned to each gene were based on a linear and continuous organization of the 
genome. However, our understanding of the genome has evolved with studies of 
histone marks and chromatin conformation. Regulatory regions are not necessarily 
adjacent to gene TSS’s. Studies of topologically associated domains, or TADs, show 
that the human genome is organized in various loops and compartments [72]. 
Furthermore, current ChIP-Enrich locus definitions do not allow overlap of loci among 
genes, which makes the assumption of a one-to-one locus to gene regulatory system. 
However, it is known that enhancers can regulate multiple genes, and some genes have 
multiple enhancers [134]. We are currently developing more biologically realistic locus 
definitions that make use of enhancer databases to better define promoter and 
enhancer regions of genes.  
 In our analysis of 63 ENCODE datasets, we observed that histone modification 
ChIP-seq experiments tend to call more peaks and broader peaks. ChIP-Enrich reduces 
peak information to a binary indicator, i.e. either a gene has no peaks or at least one 
peak, and peaks are only defined by their midpoints. This is not the best approach for 
histone modification data as peaks can occur in almost all genes and may even span 
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multiple genes. As a follow-up to ChIP-Enrich, we developed Broad-Enrich [37], which 
uses the locus proportion covered by a peak instead of a binary peak indicator. In doing 
so, Broad-Enrich has improved power for histone data compared to ChIP-Enrich. Broad-
Enrich is not limited to histone data as we have showed in Chapter 4. It can also be 
used with experiments that result in many genomic regions, especially occurring 
frequently throughout the genome (like transposons), and/or broad genomic regions 
(like segmental duplications). 
 Our analyses of ChIP-seq data has thus far been limited to comparing gene sets 
to one another. However, across different cell lines and different DNA-binding proteins, 
genes in the same gene sets may be regulated similarly. Some genes may be regulated 
by the proximal promoter, others more so from distal regions. These patterns of 
regulation may be observed on a global scale, i.e. not just limited to one cell line or one 
DNA-binding protein. This approach can give insight into more detailed regulatory 
patterns of genes and gene functions. 
5.2.2 Chapter 3 
 We showed improved type I error in RNA-Enrich when we correct for the 
relationship between significance values and average read count, however we 
acknowledge that the results from our permutations are still not perfectly uniform as 
there are more gene sets with p≤0.05 than expected. There is evidence that sequences 
with high GC content more easily amplify compared to those that are not [8, 135, 136]. If 
GC content perpetuates at the gene set level, it may affect enrichment results. Other 
factors that may affect read alignment is mappability. Though we show in Chapter 4 that 
exons are most mappable, alternative splicing may result in a transcript that includes 
typically non-coding regions, which tend to be less mappable. Overall read coverage 
can also affect differential expression testing, which is not mutually exclusive of GC 
content bias. The dataset of A549 cells treated with Dex had higher coverage than the 
other two datasets we used, suggesting that the relationships we observed between 
differential expression significance values and average read count per gene may 
become less prominent with deeper sequencing. It would be of interest to apply RNA-
Enrich to more datasets of varying read coverage. 
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5.2.3 Chapter 4 
 Transposons are a rich field of study. We have only performed our analyses on 
Alu and L1 elements, however there are 42 other repeat families in the UCSC genome 
browser “rmsk” table. For example, human endogenous retroviruses (HERVs), a type of 
long terminal repeat (LTR), comprise 5-8% of the human genome and have been 
implicated in cancer and as an inducer of genetic instability, methylation, transactivation 
and RNA interference. HERVs have been shown to act as promoter, enhancer, and 
transcriptional factor-binding site to potentially regulate neighboring genes [137]. 
Associations of HERVs with gene function may provide some insight into their evolution 
in the genome. Also of interest is examining whether the age of L1 elements is 
associated with gene function. Younger L1 elements tend to be located closer to genes 
than older elements [138] , whereas full length L1 elements are more abundant on sex 
chromosomes [139] and have been implicated in X-inactivation [115].  
Thus far, we have only performed enrichment of repeat elements in human. We 
have performed gene set enrichment of mappability and gene length in mouse but will 
also perform the same analysis for repeat elements. Of particular interest is the 
relationship between gene function and transposons. In the evolutionary timeline, 
primate-rodent split of 7SL RNA derived elements (the origin of Alu elements in human, 
and B1 elements in mouse) diverged about 80 million years ago. The result was 
independent amplification, duplication and mutation accumulation in copies of Alu and 
B1 elements [140, 141]. While the sequences of L1 elements are similar between 
human and mouse, in mouse B1 elements are the most prominent SINEs. We 
hypothesize that we will find similar gene functions enriched with B1 in mouse as Alus in 
human, as it has been shown that Alu and B1 elements have similar distributions in 
genomic features, for example, both are more prominent in upstream promoter regions 
of genes [130]. If our hypothesis holds true, this would be evidence for conserved 
evolutionary selection pressures, and identify which gene functions, despite 
independent evolution and accumulation of of Alu and B1 in human and mouse, may 
benefit from maintaining or deleting repeats in the various regulatory regions of the 
associated genes. 
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Also of interest in comparing mouse and human is the relationship of segmental 
duplications and gene function. Bailey, et al [142] and, more recently, She, et al [143] 
found that while the distribution of segmental duplications in humans are interspersed 
over large genomic distances, in mouse, segmental duplications are more locally 
clustered, taking the form of tandem duplications. Many of the identified mouse 
segmental duplications were copy number polymorphisms of immune response genes; 
similarly we found segmental duplications were also enriched in immune response 
genes in human. However, it is worth investigating if the differences in genomic 
architecture of segmental duplications in mouse and human perpetuate to differences in 
gene functions.  
Further exploration of mappability in our GSE methods and different HTS data 
will show to what degree mappability improves performance and biological findings. For 
example, mappability may play an even larger role in bisulfite sequencing data, where 
unmethylated cytosines have been converted to uracil (and read as thymine on 
sequencers). The genome is essentially reduced to a three letter alphabet, significantly 
reducing the unique information content of short read sequences. 
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